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Abstract 
Malaria is one of the major health problems in the world, especially in many 
developing countries and Plasmodium falciparum causes the majority of infection. 
The efficacies of fragments 42-kDa and 19-kDa at the C terminus (MSPI42 & MSPI19) 
of merozoite surface protein 1 (MSPl) of P. falciparum in inducing protective 
immunity were suggested as two leading malaria vaccine candidates. However, in a 
previous work, our group was not successful in detecting the mRNA or protein of 
MSPl42 in transgenic plants. To improve expression, the destabilizing signals in 
mRNA were avoided and codon usage was optimized, through sequence modification. 
The expression of the modified genes was detected, firstly, in transient expression 
study by using (3-glucuronidase (GUS) as a reporter gene and then in transgenic 
Arabidopsis in the present study. Transgenic Arabidopsis with homozygous 
transgenes were generated subsequently and the expression of the modified MSPI42 
and MSPl 19 were detected at RNA level but not protein level. 
Further optimization of transgene expression was attempted by fusing the 
modified MSPl cDNAs either with protein-targeting sequences, BP-80, a-TIP and 
r M R or GUS. These two sets of expression constructs, driven by the seed-specific 
phaseolin promoter, were studied using tobacco as a model plant system. Transient 
assay of the GUS fusion constructs was performed before plant transformation and the 
constructs without phaseolin signal peptide could give protein expression. As 
glycosylation of the GUS protein with signal peptide in the secretary pathway will 
inactivate the GUS activity, modified GUS gene was made. Expression of all these 
constructs in plant was detected by northern and western blotting, amounting to 0.4% 
of total extractable seed protein, except constructs RMR or GUS without phaseolin 
V 
signal peptide. This level of protein expression represents a significant improvement 
in producing the MSPl protein in plant system. The trans gene expression of the 
malaria surface antigen by the protein-targeting or GUS fusion strategy in this study 
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Chapter 1 General Introduction 
Malaria is one of the major health problems in the world, especially in many 
developing countries. It is caused in human by four species of Plasmodium protozoa 
parasite and P. falciparum is the species that causes the majority of infection. 
Between 300-500 million people in the world are infected with the disease. The 
global resurgence of malaria, because of the spread of drug-resistant P. falciparum, 
brings further burden to the world, especially the developing countries. This burden 
intensifies our efforts to develop a malaria vaccine, especially inexpensive and 
affordable ones. 
Using plants as expression system for vaccine production is an attractive 
option because of the low production cost, safety to human and functional antigen 
production. It will more desirable if plants can serve as edible vaccine, as costs of 
purification, manufacturing and administration will be greatly reduced. 
Merozoite surface protein 1 (MSPl) of P. falciparum was found to protect the 
Aotus monkeys from a lethal challenge with the parasites (Chang et al, 1996). Both 
the two C-terminal fragments, MSPl42 & MSPli9, of MSPl are potential candidates 
for vaccine production, because they were shown to be functional antigens against the 
parasites. 
Our group has been trying to use plants as bioreactor to produce these two 
leading malaria antigens, MSPI42 & MSPli9. However, codon usage problem and 
destabilizing signals in the mRNA of MSPl in the plant system have resulted in 
expression of undetectable to low level of truncated mRNA and undetectable protein 
of MSPI42 in transgenic plants. Modification of the cDNAs was then carried out. 
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Subsequent studies of the modified MSP 142 by our group revealed that 
recombinant MSPI42 could be produced as 0.2% of total soluble protein. This 
expression level represents a great improvement as only 0.0035% of MSP 119 was 
detected by another group (Ghosh et al., 2002). 
In this study, further optimization was attempted using the strategies of fusing 
the MSP 142 and MSP 119 with protein-targeting signals or GUS. We reason that target 
foreign proteins to appropriate compartments may enhance their stable accumulation. 
Thus PeabpSO (BP-80), a-tonoplast intrinsic protein (a-TIP) and ReMember-RingH2 
membrane protein (RMR) were used in the chimeric constructs. BP-80 can target a 
foreign protein to the globoid portion of the protein storage vacuole (PSV) via the 
Golgi; a-tonoplast intrinsic protein (a-TIP) directs a protein to the PSV, bypassing the 
Golgi; RMR targets the protein to the crystalloid region of the protein storage 
vacuole. 
As GUS protein can be expressed stably in plant system, we also reason that 
fusion of a target protein with GUS may also provide stabilizing effect to the protein. 
In addition, GUS serves as a marker at the same time to indicate the introduction of 
the transgene in the plant system. Since glycosylation of the GUS protein in the 
secretory pathway inactivates its GUS activity, modified GUS gene was thus made. 
Transient assay by using particle bombardment was firstly used to test the 
transcribability and translatability of the GUS fusion constructs before their 
transformation into tobacco. 
2 
Chapter 2 Literature Review 
2.1 Malaria 
Malaria is one of the major health problems in the world, with 102 countries 
being affected and nearly ten percent of the global population suffering from it 
annually (Shi et al., 1996). The World Health Organization (WHO) estimated that 
300-500 million cases of malaria with 1.5-2.7 million deaths occur each year. The 
disease is concentrated in the developing countries, for example, in sub-Saharan 
Africa alone, more than 150 million clinical cases with up to 2 million deaths every 
year (Moorthy and Hill, 2002). The bulk of malaria-related morbidity and mortality in 
an endemic setting is concentrated in children below the age of five, for instance, in 
Africa, million of children die from this disease every year (Miller et al., 2002). 
The control of malaria becomes less successful because of the occurrence of 
drug-resistance parasite. This brings economic burdens to many countries (Oaks et al., 
1991). Therefore, new drugs, especially inexpensive and affordable one, and more 
practical formulations of existing drugs/compounds are badly needed. 
3 
2.2 History of Malaria 
Before 1950, malaria caused a major death in the central highlands of the 
African island nation of Madagascar, but in the late 1950s, malaria virtually 
disappeared as an aggressive insecticide spray was carried out and a victory in the 
battle against malaria achieved in 1970s. However, the disease reinvaded the 
highlands in the early 1980s as the spraying program stopped. This caused another 
boom of death as the older population had lost the partial immunity they once had and 
the younger one did not have any immunity to the disease (Oaks et al., 1991). Then, 
by the use of antimalarial drugs, such as chloroquine, with outstanding properties 
against malaria and the slow speed of drug resistance developed by the parasites, 
malaria had been controlled for many years later. However, nowadays, malaria 
parasite has developed resistance to the antimalarial drugs to certain extent (Ridley, 
2002). Therefore, developing an effective antimalarial drug or vaccine is urgent in 
need. 
2.3 Malaria parasite 
Malaria is a disease caused by protozoan parasites of the genus Plasmodium 
which has a complex life cycle between the mosquito vector and the human host. 
These are four species of single-cell highly specific Plasmodium protozoa parasites: P. 
4 
falciparum, P. vivax, P. ovale, and R malaria that cause malaria in humans, of which P. 
falciparum is the most pathogenic, accounting for the majority of infections and the 
most fatal (Oaks et al., 1991; Wipasa et al, 2002). 
2.4 Life cycle 
The life cycle of malaria parasite is complex and can be divided into three 
phases: the liver phase, blood phase, and the mosquito phase. (Oaks et al； 1991; 
Miller et al., 2002; Moorthy et al； 2002) 
Liver stage (pre-erythrocytic stage) 
The malaria parasites, in the form of sporozoites with about 5-20 in number are 
injected by the malaria parasite carrier female mosquito into the human host through 
each biting, usually into the subcutaneous tissue. Then, the sporozoites migrate 
through bloodstream within minutes and enter hepatocytes in which the sporozoites 
multiplies and differentirates into a liver-stage trophozoites (Moorthy et al., 2002). 
Blood stage (asexual blood stage) 
In liver, each schizont which differentiates from a trophozoite during hepatocyte 
lysis releases 10,000 -30,000 merozoites which are able to invade other red blood 
cells. Afterward, cycles of red blood cell invasion with red blood cell lysis is triggered 
continuously until the death of the human host or control by the immune system of the 
5 
host (Miller et al； 2002; Moorthy et al； 2002). 
Mosquito stage (sexual blood stage) 
Some merozoites will differentiate into gametocytes which will be ingested by 
an anopheline mosquito. After, in the female mosquito, the gametocyte develops into 
oocyst and then sporosite which swims to the salivary glands to complete the life 
cycle. If the infected mosquito bites on a human host, the sporosite will be injected to 
the human host and another infection will be caused (Moorthy et al., 2002). 
2.5 Potential use of malaria vaccine 
The idea of malaria vaccine is feasible as its potential use was supported by 
several studies, including for example, diversity of immune responses in humans to 
malaria antigens (Richie and Saul, 2002); stimulation of protective immunity in mice 
by the injection of X-irradiated sporozoites (Nash et al,, 1967); passive transfer of 
human immunity by vaccination with potential candidate, y-globulin purified from 
human serum (Cohen, 1961); different extents of protection of the rodents by using 
recombinant protein of malaria antigen (Chang et al., 1996; Kumar et al,, 2000; 
Stowers and Chen et al., 2002; Stowers and Kennedy et al., 2002); and protection of 
mice from blood-stage challenge with sporozoites by the use of malaria DNA 
vaccines (Gardner et al., 1996). 
6 
There are many potential targets for vaccination because of the complex life 
cycle of the malaria parasite. For instance, antibodies to sporozoites and interferon 
gamma can respectively prevent invasion of hepatocytes and inhibit the development 
of liver stage; antibodies to merozoites can prevent the invasion of red blood cells; 
and antibodies to gametocytes can prevent development into sporozoites (Oaks et al., 
1991; Holder, 1999). As asexual blood stage is the only stage of the parasite life cycle 
that causes clinical symptoms and death in human host, it is thus a potential candidate 
for vaccination. Among these potential candidates, P. falciparum merozoite surface 
protein 1 (MSPl) is the most studied. 
2.6 Merozoite Surface Protein 1 (MSPl) 
The merozoite surface protein 1 (MSPl) is naturally immunogenic. Immunization 
of nonhuman primates with native or recombinant MSP-1 was found to develop 
various degrees of resistance to the challenge of P. falciparum (Egan et al, 1997). 
MSPl, the major surface membrane-associated protein expressed by merozoites 
during the asexual erythrocytic stage, is a relatively abundant protein which has been 
found in all Plasmodium species examined. 
MSPl is synthesized as a high molecular mass precursor protein, with 195 kDa, 
which is proteolytically processed into four smaller fragments (Wiser et al, 1996; Shi 
7 
et al, 1996; Wu et al, 2000). The proteolytic processing of MSPl is a two-step 
procedure characterized by primary and secondary processing events. The primary 
processing occurs at, or just before, the terminal merozoite differentiation and results 
in the formation and release of a noncovalent polypeptide complex with four 
fragments of approximately 83, 30, 38 and 42 kDa (Egan et al, 1997). These discrete 
products reside on the surface of the merozoite, but most of these fragments disappear 
at the time the merozoite invades the erythrocyte (Shi et al, 1996). 
The secondary processing results in the shedding of a soluble MSPl. The 42 kDa 
C-terminal fragment which is directly attached to the merozite surface via a 
glycoslphosphatidylinositol anchor is further processed into 33 and 19 kDa fragments 
at the time of merozoite invasion, i.e. during subsequent contact with an uninfected 
erythrocyte. The 33 kDa fragment is shed from the merozoite surface prior to 
erythrocyte invasion and the remaining glycosylphosphatidylinositol-anchored 19 
kDa fragment which contains two epidermal growth factor-like modules is carried 
into the erythrocyte upon merozoite invasion (Egan et al, 1997). 
2.7 Potential use of MSPl 
The P. falciparum MSPl is a blood stage antigen which has been studied 
extensively. Although MSPl is polymorphic, its cysteine-rich carboxy-terminus 
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shows only four single amino acid changes among the strains. Also, nonhuman 
primates could be protected from the challenges of P. falciparum by vaccination with 
MSPl produced by parasite culture (Chang et al, 1996) and an immune response to 
MSPl is expected to stop merozoite invasion of erythrocytes 一 the developmental 
stage of the parasite that causes clinical malaria. (Marriott et al, 2000). Therefore, it is 
a potential vaccine candidate. 
However, a correct expression system of the MSPl should be used for the 
production of a functional antigen because the sequence encoding the protective 
MSPl epitopes, which are disulfide-dependent conformation, may play an important 
role in immunity (Chang et al, 1996; Wu et al, 2000). For example, by the use of 
recombinant MSPl polypeptides produced by a bacterial expression system, no level 
of immunity to P. falciparum infection was determined when compared to those 
produced by parasite (Chang et al, 1996; Wu et al, 2000). 
2.8 Significance of MSPl C-terminal fragments 
2.8.1 Significance of M S P I 4 2 
The 42-kDa fragment of the C terminal of MSPl (MSPl42) contains a cluster of 
cysteine residues which are highly conserved among the divergent Plasmodium 
species and these cysteine residues contribute to the disulfide bonds which participate 
9 
ill conformation epitopes. These conformational epitopes of MSPI42, gp-195-specific, 
are critical for the induction of parasite growth-inhibitory antibodies (Chang et al, 
1992). For example, MSPl specific antibody was produced in Aotus monkeys after 
immunization with BVp42, a baculovims recombinant polypeptide based on the 
MSPl (Chang et al, 1996), and an inhibitory activity of anti- MSPI42 antibodies from 
rabbit serum against malaria parasites was observed (Pang et al, 2002). 
The immunogenicity and protective efficacy of a baculovims recombinant 
polypeptide based on the MSPl has been evaluated in Aotus lemurinus griseimemhra 
moneys. Immunization of Aotus monkeys with BVp42 resulted in high antibody titers 
against the immunogen as well as parasite MSPl with closely approximate the 
antgenicity and immunogenicity of the native MSPl C-terminal processing fragment 
(Chang et al, 1996). Also, high-titer antibody against MSPI42 epitopes was triggered 
in rabbits which were vaccinated with the recombinant MSPl42 produced by 
virus-silkworm expression system (Pang et al, 2002). 
These findings suggest that MSPI42 contains the sequence encoding the 
essential epitopes which can be recognized by the antibody and can trigger the 
immune response in the tested animals. Therefore, MSPl42 is a potential candidate for 
malaria vaccine production. 
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2.8.2 Significance of MSPI19 
The C-terminal 19-kDa fragment (MSPl 19), the only fragment, remaining on the 
merozoite surface after the secondary processing of the 42-kDa fragment at the 
C-terminal region during erythrocyte invasion, is an ideal target for blocking parasite 
invasion into the erythrocyte (Shi et al, 1996). 
The 19-kDa fragment is highly conserved, with only four amino acid differences 
in 96 residues (Egan et al, 1997). MSPl 19 contains two cysteine-rich epidermal 
growth factor (EGF)-like domains, each of which consists of 45-50 amino acids 
contributing to the disulfide bond pattern in the critical conformational epitopes 
(Burghaus et al, 1993; Morgan et al, 1999). Other research study also demonstrated 
that the antigen of the yeast-expressed recombinant 19-kDa fragment of P. falciparum 
MSP-1 processes a majority of the protective epitopes of the C-terminal 42-kDa 
region (Shi et al, 1996) and these reduction-sensitive epitopes can be recognized by 
the monoclonal or polyclonal antibodies which can stop the red blood cell invasion 
(Donnell et al, 2001). For example, natural immune response was found in human 
who lived in the malaria affected areas and showed immunization to the recombinant 
protein MSPl 19 produced by parasites (Shi et al, 1996). Also, high levels of antibodies 
to MSPl 19 were elicited in the Aotus monkeys which were vaccinated with that 
recombinant protein produced by yeast (Kumar et al, 2000). 
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2.9 Production ofMSPl C-terminal fragments 
Many different types of systems have been used for the production of the 
recombinant proteins for vaccination, such as in bacteria {Escherichia coli, 
Salmonella typhi), baculovirus, baculovims-silkworm, parasites, yeast, the milk of 
transgenic mice, mammalian cells, tobacco and Arabidopsis (Chang et al, 1992; 
Burghaus et al, 1993; Chang et al, 1996; Shi et al, 1996; Egan et al, 1997; Pan et al, 
1999; Kumar et al, 2000; Wu et al, 2000; Stowers et al, 2002; Pang et al, 2002; Ghosh 
et al, 2002; Lau, 2003). Different degrees of protein expression were found. Also, 
inhibition of parasite growth, rise of antibody levels and immunity responses were 
detected in tested individuals. 
2.10 Plants as bioreactor 
Producing desired recombinant proteins by transgenic plants benefits in 
several ways. First, the cost of plant growing is low. Second, scale up is feasible in 
planting. Therefore, a bulk quantity of the protein can be produced economically. 
Third, the ease in harvesting, transporting, storing and processing is also an 
advantage. 
There are several other potential advantages by producing proteins in plants 
over microbial fermentation, animal-cell cultures and transgenic animals, including 
for example, limited capacity for production of the accurate post-translational 
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modification of eukaryotic proteins in bacterial fermentation; substantial costs 
involved in bacterial fermentation and animal-cell culture; and public and ethical 
concerns risen by the use of transgenic animals (Kusnadi et al, 1997; Oscar et 
al,1995). 
Successful productions of materials like carbohydrates, lipids and proteins, 
such as high-value pharmaceutical polypeptides, industrial enzymes, in plants had 
been demonstrated (Oscar et al, 1995; Hood et al, 1999; Mercenier et al, 2001), for 
example, production of the B-subunit of heat-labile toxin in potato amounting to 1.8% 
of total soluble protein (Hugh et al, 1998); Norwalk vims capsid protein expressed in 
transgenic tobacco and potato with orally immunogenic in mice (Mason et al, 1996); 
and hepatitis B surface antigen expressed in transgenic tobacco and immune response 
in mice fed with the hepatitis B surface antigen transgenic potato tubers (Mason et al, 
1992; Richter et al, 2000). 
Vaccine production by the use of plants has potential advantages over the 
traditional methods, for example, eliminating the chance of infection to innate toxic as 
subunit of the pathogen or toxin is produced in plant; avoiding pathogen 
contamination, as no known human or animal pathogens that are infections to plants; 
formulating multi-component vaccines by breeding the seed of transgenic lines 
expressing different proteins; and producing oral vaccine by expressing the desired 
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protein in the commonly consumed food plants (Streatfield et al, 2001). 
2.11 Expression of MSPl C-terminal fragments in transgenic 
plants 
The expressions of MSPl C-terminal fragments in transgenic plants were 
studied previously (Ng, 2001; Ghosh et a l , 2002; Lau, 2003). 
Expressing MSPI42 and MSPl 19 in tobacco and Arabidopsis were performed 
by our group previously (Ng, 2001; Lau, 2003). Initially, the cDNA, encoding 
MSPI42 of the P. falciparum Uganda Palo Alto (FUP) strain, was cloned and 
expressed using the Phaseolin promoter. However, only a very low amount of mRNA 
of MSPl42 was detected in some transgenic Arabidopsis lines by RT-PCR and no 
signal was observed in all lines by northern blot analysis. Also, no mRNA was 
detected in all transgenic tobacco lines by both RT-PCR and northern blot analysis. 
And no protein or positive result was detected by both western blot and particle 
bombardment using GUS fusion to the C-terminal of MSPI42 cDNA. These suggested 
that MSPl42 could not be expressed in transgenic plants at the protein level, as well as 
at the RNA level (Ng, 2001). 
The failure of gene expression of MSPl42 may be due to several reasons. 
First, within the intron of the MSPl42 sequence, the AT-richness of transgene may 
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facilitate pre-mRNA splicing in plants. Second, the presence of ATTTA pentamer in 
MSPl42 is a mRNA destabilizing sequence causing instability of the reporter 
transcripts (Ohem-Takagi et al., 1993). Third, the AATAAA/AATAAA like-motifs in 
MSPl 42 as polyadenylation signals (Joshi, 1987), will cause premature 
polyadenylation. Fourth, the occurrence of A+T in third degenerate base in the 
MSPl42 sequence may cause codon usage problem. In addition, the presence of 
codons in flgp42-His cDNA that are rarely used in plants. These four factors may 
have caused the failure of the gene expression at both transcriptional and translational 
levels. 
Therefore, the MSPl42 was modified previously in our laboratory to decrease 
the AT content of the sequence from 70.6% to 50%. All 9 ATTTA pentamers as well 
as 24 AATAAA/ AATAAA-like motifs were avoided. Moreover, the modified MSPl42 
is having 81.2% codons in which G/C is at the third degenerate base. Furthermore, 
























Figure 2-1 Nucleotide sequences of malaria surface protein 1，42- and 19-kDa 
(MSPI42 & MSP1i9) fragment cDNAs of the Plasmodium falciparum Uganda 
Palo Alto (FUP) strain 
Nucleotide sequences of MSPI42 cDNA (1122 bp) and M S P l 19 (303 bp, underlined) 
showing the AT-richness of coding region, the presence of ATTTA destabilizing 






















Figure 2-2 Nucleotide sequence of malaria modified flgp42-His cDNA 
Nucleotide sequence of \heflgp42-His cDNA showing the modified bases (red). 
After modification, the expression of the MSPI42 and it fragment, M S P l 19，in 
plants was markedly improved at both transcriptional and translational levels (Lau, 
2003). 
In the study of expressing MSPI42 and M S P l 19 in transgenic tobacco, the 
highest level of expression of M S P l 19 of total soluble protein was at 0.0035% (Ghosh 
et al.’ 2002), while 0.2% was found for MSPl42 in which the protein was fused with 
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AFVY, a phaseolin signal peptide (Lau, 2003). The low expression level of the 
MSPl 19, as 0.0035% of total soluble protein (TSP), under the control of 35S promoter 
of cauliflower mosaic vims, in tobacco plants was explained by Ghosh et al (2002) 
due to the large number of cysteine residues in the MSPl 19 protein and also the 
presence of disulfide bridges which cause the degradation or destabilization of the 
protein molecule in the highly reducing condition of cytoplasm (Bosch et al., 1994; 
Florack et al, 1994). 
For our group, to improve the expression, the MSPl42 was fused with lysine 
rich protein (LRP) or a phaseolin-targeting signal (AFVY), a necessary determinant 
for the vacuolar sorting (Frigerio et al., 1998; Frigerio et al., 2001), and these 
constructs was transformed into Arabidopsis or tobacco (Lau, 2003). The MSPI42 was 
detected by western blot analysis in both types of constructs and the expression level 
of MSPl42-AFVY was found to be expressed at a higher level than the LRP- MSPI42 
(Lau, 2003). Also, the expression level of the MSPI42, at 0.2%, was much improved 
when compared with that of Ghosh et al. (2002) at 0.0035%. This suggests that 
expressiing of MSPl protein and its fragments in plants should be stabilized by 
cellular compartment sorting or fusion with a protein which can be expressed stablily 
in a plant system, such as the lysine rich protein. 
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2.12 Phaseolin and its sorting signal 
Phaseolin, a homotrimeric soluble glycoprotein that is synthesized during seed 
development and accumulates in protein storage vacuoles of protein bodies, is the 
major storage protein in bean {Phaseolus vulgaris) (Sturm et al., 1987; Frigerio et al., 
1998). This major storage protein of the French bean was isolated (Sun et al., 1981) 
and the complete nucleotide sequence was determined (Slightom et al., 1983). The 
expression of phaseolin gene and its promoter had been studied. The phaseolin gene 
was found to express at a higher level in the seeds of trans formated tobacco plants and 
the phaseolin promoter functions in the embryonic tissue in tobacco seeds 
(Sengupta-Gopalan et al., 1985). The phaseolin promoter has been utilized in 
expressing foreign protein in plants because of its strong and seed-specific expression 
(Hoffman et al” 1987; Altenbach et al., 1989; Altenbach et al., 1992 and). 
The vacuolar sorting of phaseolin was shown to be very efficient in tobacco 
leaf cells while the sequence Ala-Phe-Val-Tyr (AFVY), a highly hydrophobic 
sequence, at the C-terminal of the phaseolin was used. However, the protein will be 
secreted by Golgi-mediated secretion if the protein expression is at a high level, a 
saturation level. On the other hand, the phaseolin without AFVY will be secreted 
completely from the cells and accumulates in the extracellular medium (Frigerio et al., 
1998). 
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Also, in a previous study, we found that the fusion construct of MSPl42 with 
AFVY showed a higher protein expression level, at 0.2% of the total soluble protein 
(TSP) over the MSPI42 without the AFVY signal (Lau, 2003). This level is much 
higher then the previous report on 0.0035% TSP obtained by Ghosh et al (2002). 
Thus AFVY appears to be capable of directing foreign proteins to plant vacuole for 
stable accumulation. 
2.13 Protein Targeting Sequences 
Accurate foreign protein sorting is important for the success of the target 
protein production in plant cells because soluble enzymes, which may digest the 
target protein, are present in all subcellular compartments, such as cytosol, the lumen 
of the endoplasmic reticulum (ER), cistemae of the Golgi apparatus and cell wall. 
Therefore, directing the target proteins to a certain cellular compartment for stable 
accumulation may be one of the critical factors for enhancing the yield of 
recombinant protein production. 
Both lytic vacuoles and protein storage vacuole (PSV) present in plant cells. 
Plant seeds are generally rich in protein with a large percentage of the soluble proteins 
stored in the protein storage vacuole, so sorting the target protein to this compartment 
may help improve protein production (Jiang and Sun, 2002). 
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Specific sequences derived from the transmembrane domain (TMD) and 
cytoplasmic tail (CT) are required for the integral membrane protein sorting to 
specific vacuoles. The peabp80 (BP-80), a-tonoplast intrinsic protein (TIP) and 
ReMember- RingH2 membrane protein (RMR) were used in this study, 
(a) PeabpSO (BP-80) 
PeabpPSO, consisting of a large luminal domain, a single TMD and a CT, 
contains a peptide sequence with very high degree of conservation in the Arabidopsis 
family. However, it is unclear if all the peabpSO homologues are involoved in sorting 
proteins to the lytic vacuole. 
PeabpSO TMD alone was found to be sufficient in membrane anchoring, for 
example, in lytic prevacuolar targeting in tobacco cells (Jiang and Roger, 1998) but 
not sufficient to accumulate the foreign protein in the prevacuole. Whereas, CT of 
BP-80 has a dominant role for localization because trans-Golgi network (TGN) and 
prevacuole targeting information does not residue within the TMD. When the CT 
works together with TMD in a fusion protein, the protein was found to be directed via 
the Golgi to lytic vacuole, in vegetative plant cells, and globoid in the PSV in plant 
seeds (Jiang and Rogers, 1998; Saint-Jore-Dupas et al, 2004). 
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(b) a-tonoplast intrinsic protein (a-TIP) 
a-tonoplast intrinsic protein (a-TIP), which presents in the membrane of PSV, 
serves as an indicator of PSV. The intact a-TIP, with a-TIP TMD and CT were found 
to target a reporter protein to tonoplast (Jiang and Rogers, 1999). 
a-TIP CT with BP-80 TMD will target protein, by passing through Golgi, to 
PSV with the same colocalization with the intact a-TIP protein (Jiang and Rogers, 
1998) and this targeting sequence was used in the presnet study of MSPl42 and 
MSPl 19 and is simplifyly named as a-TIP. 
(c) ReMember-RingH2 membrane protein (RMR) 
ReMember-RingH2 membrane protein (RMR), which is predicted from a 
tomato EST clone with high similarity to that of the Arabidopsis protein, was 
identified by Jiang et al. (2000). RMR was present exclusively in the membrane 
fraction and remained intact. The reporter protein which was fused with TMD and CT 
of RMR was found to be trafficked to the protein storage vacuole via the Golgi 
(Saint-Jore-Dupas et al, 2004). 
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Chapter 3 Materials and Methods 
3.1 Introduction 
Arabidopsis and tobacco were used as model plants for expressing MSPl42 and 
MSPl 19 cDNAs. The expression of the modified MSPI42 or MSPl 19 cDNA was tested in 
transgenic Arabidopsis, while those in either protein targeting fusion constructs or 
(3-glucuronidase (GUS) fusion constructs were tested in transgenic tobacco. 
Transient assay by using particle bombardment was used to test for transient 
expression of MSPl 42 or MSPl 19 cDNA fused with reporter p-glucuronidase (GUS) gene. 
3.2 Chemicals and enzymes 
All the chemicals used were of reagent grade or molecular grade (unless 
otherwise specified) and were purchased from Sigma Chemical Co. or Bio-Rad Co. 




3.3.1 MSPI42 and MSPl 19 constructs 
Two chimeric gene constructs containing modified MSPl42 and MSPl 19 in phaseolin 
cassette were prepared by Ng, early (Ng, 2001). 
Phasp MP42 Phast 
Phasp MP 19 Phast 
Figure 3-1 Constructs of MSPI42 and MSPli9in Phaseolin cassette 
In these constructs, phaseolin promoter (Phasp) and terminator(Phast) were used to drive 
the expression of modified MSPl42 (MP42) and modified MSPl 19 (MP 19) 
3.3.2 Protein targeting fusion constructs 
Altogether eight chimeric constructs, 1) MP42, MP42 with protein targeting 
signals: 2) BP-80, 3) a-TIP and 4) RMR (MP42-BP-80; MP42-a-TIP and MP42-RMR); 
5) MP 19, MP19 with protein targeting signals: 6) BP-80, 7) a-TIP and 8) RMR 
(MP19-BP-80; MP 19- a-TIP and MP19-RMR) were included in this study. The target 
gene MP42 and MP 19 were PGR amplified, using pTZ.Phas/MP42 as a template, for the 
introduction of 5'NdeI and 3' AccI sites. The primers sequences are as shown in Figure 
3-8. A 50|dl PGR reaction mixture containing 40ng DNA template, IX Pfu buffer 
(Strategene), 0.2mM dNTP, O.SjiM 5' primer, 0.5|aM 3' primer and 2.5units Pfu DNA 
polymerase (Strategene, 2.5u/|li1) was prepared for each of the target gene. The PGR 
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conditions were as follows: 94�C for 5 minutes, then 30 cycles of 9 4 � C for 30 seconds, 
58°C for 30 seconds and 7 2 � C for 30 seconds, followed by 1 cycle of 7 2 � C for 10 minutes. 
Then, the PGR product was used for agarose/ TAE gel electrophoresis. 
The PCR products were cloned into pGEM-T vector (Promega) in order to 
increase the restriction digestion efficiency by AccI and Ndel. 
To amplify the target genes: 
MP42: primers LNspM42 + RANM42 using pTZ/Phas/MP42 as template 
MP42-BP-80: primers LNspM42 + RASM42 using pTZ/Phas/MP42 as 
template 
MP42-aTIP: primers LNspM42 + RASM42 using pTZ/Phas/MP42 as template 
MP42-RMR: primers LNspM42 + RASM42 using pTZ/Phas/MP42 as template 
MP19: primers LNspM19 + RANM42 using pTZ/Phas/MP42 as template 
MP19-BP-80: primers LNspM19 + RASM42 using pTZ/Phas/MP42 as template 
MP19-aTIP: primers LNspM19 + RASM42 using pTZ/Phas/MP42 as template 
MP19-RMR: primers LNspM19 + RASM42 using pTZ/Phas/MP42 as template 
A stop codon was included at the 3' end of MP42 and MP 19, but not for those 
constructs containing the protein targeting genes. The target gene was then excised using 
Ndel and AccI and was cloned into pBK/Phas/SP vector which contains a phaseolin 
promoter cassette and a phaseolin signal peptide. 
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Protein targeting sequences BP-80, a-TIP and RMR were PGR amplified as 
mentioned above for the introduction of AccI site at both ends. The PCR products were 
cloned into pGEM-T vector for efficient restriction digestion by AccI. 
To amplify the protein targeting gene: 
BP-80: primers Acc491-L + RABP-80 using 
PSB130/Gtl/SP/hG-CSF/TMD/BP80 (from Prof. Jiang, Biology 
Department, CUHK) as template 
a-TIP: pnmers Acc491-L + RAaTIP using PSB130/Gtl/SP/hG-CSF/TMD/aTIP 
(from Prof. Jiang, Biology Department, CUHK) as template 
RMR: primers Acc727-L + RARMR using PSB13 0/Gt 1 /SP/hG-CSF/TMD/ RMR 
(from Prof. Jiang, Biology Department, CUHK) as template 
The protein targeting gene with the MP42 or MP 19 was cloned in frame by 
AccI sites into the pBK/Phas/SP vector containing phaseolin promoter cassette as well as 
a phaseolin signal peptide. The orientation of the protein targeting gene in the 
pBK/Phas/SP vector was checked by PCR as mentioned above using 5' primer of MP42 
or MP 19 and 3' primer of the protein targeting gene. 
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(a) For Phas/SP/Mp42 and Phas/SP/MP19: 
To amplify MP 19 To amplify MP42 
Ndel Ndel 
Phasp MP42 Phasp Phasp MP42 Phasp 
^ _ - 乂 k ^ 乂 s 
p T Z AccI J p T Z AccI 夕 
A- Ndel Accl-A ^ ^ T T ^ ^ 
Target gene � pGEM-T J 
ligation 
Ndel AccI 










^ ^ Phasp SP Target gene Phast 
pBK ^ ^ ^ ^ ^ ^ ^ ^ 
27 
(b) For Phas/SP/MP42 and Phas/SP/MP19 with protein targeting signal: 
To amplify MP42 To amplify MP 19 
Ndel Ndel 
^ � 
Phasp MP42 Phasp Phasp MP42 Phasp 
^ ^ ^ k ^ _ _ 一 乂 K 
v . p T Z AccI J p T Z AccI 夕 
A- Ndel Accl-A 
T T ^ ^ 
Target gene 广  
^ ( pGEM-T ) 
ligation ^ 一 ^ ^ ^ ^ ^ ^ ^ 
/ 
Ndel AccI 
C Target gene ^ ^ ^ AccI AccI 
J Protein Targeting gene 
pGEM-T ^ ^ ^  
yEnzyme digestion / accI Acd  
Ndel AccI / 
/ ^ ^ Phasp SP Phast ^ ^ 
Target gene / ^ 
— — \ 
Ndel AccI AccI 
Phasp SP Target gene Protein Trageting Phasp 
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Figure 3-2 (a and b) General scheme for the construction of protein targeting 
constructs 
Target gene represents either MP42 or MP 19. Phasp = phaseolin promoter; SP = 
phaseolin signal peptide; and Phast = phaseolin terminator. Protein targeting gene 
represents the inclusion of a-TIP, BP80 or RMR. 
29 
3.3.3 Gus fusion Constructs 
(a) Particle bombardment 
All together six constructs were included in this part. The P-glucuronidase (GUS), 
with the start codon excluded, was fused with the 1) modified and 2) unmodified MSPl42 
and 3) modified and 4) unmodified MSPl 19, and with GUS 5) with and 6) without a start 
codon as positive control and negative control, respectively. 
Phasp GUSATG Phast 
Phasp GUSN Phast 
Phasp MP42 GUSN Phast 
Phasp P42 GUSN Phast 
Phasp MP 19 GUSN Phast 
Phasp PI 9 GUSN Phast 
Figure 3-3 The MSPI42 and MSPI19 GUS fusion constructs used in particle 
bombardment 
A total of six constructs, using GUS as a reporter gene, in single and in fusion with MP42 
and MP 19, in studying the expression of modified MP42 and MP 19. GUSATG, in which 
the GUS gene retained its ATG; GUSN, without the ATG codons. 
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Cloning of pTZ/Phas/MP19::GUSN 
pTZ vector with phaseolin promoter and terminator was prepared from the 
digestion of pTZ/phas/MP19 by AccI while, MP 19 fragment was prepared from the 
digestion of pTZ/phas/MP 19 by AccI and PstL Moreover, the GUS gene without ATG 
(GUSN) was prepared from the digestion of pTZ/phas/MP42 DNA fragment by AccI and 
PstL 
A c c 1 Pst 1 A e e 1 A c c 1 Pst 1 
A c c 1 Pst 1 A c c 1 
M P 1 9 MP 19 
PbJfe^ lP n m t Hi 如 p Phast 
PTZ pTZ ( L ^ ^ _ _ I ) 
mm-rn'Mmmmmm^--' ..mmmmmm....…… 
Cut by Acc 1 Cut byAcd and Pst 1 
• • psti • 
ACC1 ACCI _Pst 1 ACC1 
f'has p PL.> 1 * MP 19 GUSN ' ' 
P T � 
^ ^ / ^ ^ 
A c c 1 Pst 1 A c c 1 
i h a ^ P MP19 (.1 SN Phas i 
， J „ 
々 办 縱 緣 m m m m • • 麗 徹 … / 」 〜 激 / 身 广 / / 磁 / " / 々 ' 耀 份 ' 
Figure 3-4 Construction scheme of Phas/ pTZ/ MP19::GUSN for particle 
bombardment 
Phasp indicates phaseolin promoter while Phast, phaseolin terminator. 
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(b) GUS fusion constructs for plant transformation 
In this part, altogether six chimeric constructs, including target genes MP42 and 
MP19: 1) Phas/MP42-EK::GUSN; 2) Phas/MP19-EK::GUSN; 3) 
Phas/SP/MP42-EK:: GUSN; 4) Phas/SP/MP 19-EK:: GUSN; 5) 
Phas/SP/MP42-EK:: GUSN-AFVY and 6) Phas/SP/MP 19-EK:: GUSN-AFVY, were 
prepared. 
For the first two constructs, Phas/MP42-EK: :GUSN, Phas/MP 19-EK:: GUSN, the 
MP42 and MP 19 gene was PCR amplified as mentioned in 3.3.2 to introduce a 5’AccI 
site and 3’ enterokinase (EK) plus a PstI site. The PCR products were cloned into 
pGEM-T vector for increasing the efficiency of AccI digestion. 
To amplify the MP42 and MP 19 gene, the following experiments were carried out: 
MP42: Primers LANM42 + RPEKM42 using pTZ/Phas/MP42 as template 
MP19: Primers LANM19 + RPEKM42 using pTZ/Phas/MP42 as template 
The constructs were cloned by three fragment ligation. After cloning into pGEM-T 
vector, the MP42 and MP 19 gene was excised by AccI and PstI with the removal of the 3’ 
stop codon of the gene. Also, GUSN (GUS without ATG) was released from 
pTZ/Phas/MP42::GUSN (from Ng, W. K.) under the digestion by AccI and PstI. The pTZ 
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vector with Phaseolin cassette was prepared by enzyme digestion with AccI on 
pTZ/Phas/MP42::GUSN (from Ng, W. K.). Then, three-fragment ligation was performed. 
For constructs Phas/SP/MP42-EK: :GUSN and Phas/SP/MP 19-EK:: GUSN, the 
MP42 and MP 19 gene were PGR amplified as mentioned in section 3.3.2 to introduce 
5'NdeI site and 3'enterokinase (EK) site plus Pstl. 
To amplify the MP42 and MP 19: 
MP42: Primers LNspM42 + RPEKM42 using pTZ/Phas/MP42 as template 
MP19: Primers LNspM19 + RPEKM42 using pTZ/Phas/MP42 as template 
The PCR products were cloned into pGEM-T vector. A three-fragment ligation was 
performed using the MP42 and MP 19 which were excised by Ndel and Pstl from the 
pGEM-T vector, the GUSN (GUS without ATG) which was released from 
pGEM-T/P-GUSN-A (from Ng, W. K.) by Pstl and AccI, and the pBK/Phas/SP vector 
which contains Phaseolin casetter together with Phaseolin signal peptide which was 
prepared by digestion with Ndel and AccI on pBK/Phas/SP/MP42 (section 3.3.2). 
For the constructs with AFVY, namely Phas/SP/MP42-EK: :GusN-AFVY and 
Phas/SP/MP 19-EK:: GusN-AFVY, GUSN (GUS without ATG) was PCR amplified as 
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mentioned in section 3.3.2 to introduce a 5'PstI site and 3' enterokinase (EK) site plus 
AccI. 
To amplify the GUS gene, the following experiments were carried out: 
EK::GUSN-AFVY: Primers LPEKGus + RAAFVYGus using pBI121 as 
template 
The PCR products of amplified GUS were cloned into pGEM-T vector, the 
EK: :GUSN-AFVY was excised from the pGEM-T vector by PstI and AccI, whereas 
MP42 and MP 19 were excised by Ndel and PstI with the removal of the 3' stop codon 
from the pBK/Phas/SP/MP42 and pBK/SP/MP19 (section 3.3.2), respectively. Then, 
three-fragment ligation was performed to ligate the MP42 or MP 19 with 
EK: :GUSN-AFVY and pBK/Phas/SP vector, containing the Phaseolin casetter together 
with Phaseolin signal peptide, which was prepared by digestion with Ndel and AccI of 
the pBK/Phas/SP/MP42 (section 3.3.2). 
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(a) For Phas/MP42-EK::GUSN and Phas/MP19-EK::GUSN 
To amplify MP 19 To amplify MP42 
A c ^ A c ^ 
Phasp MP42 Phasp Phasp MP42 Phasp 
C ^ ) ( ^ ) 
p T Z EK-PstI ^ ^ p T Z EK-PstI ^ ^ 
PCR 
• T T 
A- AccI Pstl-A ( ^  
I pGEM-T ) 
Target gene EK ^ — 
• PstI AccI 
A- AccI Pstl-A  
z Phasp MP42 GUSN Phast \ 
CTarget gene EK 广 J X 
pGEM-T ^ ^ ^ ^ ^ PTZ ___ 
^ E n z y m e digestion ^ / ^ ^ z y m e digestion 
AccI PstI PstI AccI 
Target gene EK GUSN 
^ ^ AccI AccI 
^ ^ ^ ^ ^ Phasp Phast 
Three-fragment / pTZ 
ligation 丄 ~~ ^ ^ ^ ^ ^ 
AccI Pstll AccI 
, P h a s p Target gene EK GUSN Phast 
PTZ 
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(b) For Phas/SP/MP42-EK:: GUSN and Phas/SP/MP19-EK::GUSN 
To amplify MP 19 To amplify MP42 
N气I 一 N d d 
Phasp MP42 Phasp Phasp MP42 Phasp 
C ^ ) ( ^ ) 
p T Z EK-PstI ^ ^ p T Z EK-PstI ^ ^ 
PCR ^ ^ ^ ^ ^ 
• ^ A r ^ ^ ^ ^ T T ^ ^ ^ 
A- Ndel Pstl-A 广 ^  
I pGEM-T J 
Target gene EK ^  
/ ligation 
• PstI AccI 
A- Ndel Pstl-A [ 
, P h a s p MP42 GUSN Phast \ 
^ Target gene EK ^ 广 X 
pGEM-T ^ ^ ^ ^ PTZ 
^ E n z y m e digestion ^ / ^ " ^ z y m e digestion 
Ndel PstI PstI AccI 
Target gene EK GUSN 
^ ^ Ndel AccI 
^ ^ Phasp SP Phast 
Three-fragment pBK ^^ ^^ ^^ ^^ ^^ ^^  
ligation / ^ ^ ~ ~ ~ ~ ~ ---一 
AccI Pstll AccI 
Phasp SP Target gene EK GUSN Phast 
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(c) For Phas/SP/MP42-EK::GUSN-AFVY and Phas/SP/MP19-EK::GUSN-AFVY 
To amplify EK::GUSN-AFVY 
Ps t l -^ 
^ — G U S N ^ ^ ^ 
C ^ ) 
pGEM-T AF-AccI ( v p ^ 
PGR 
V ^ ^ ^ T T ^ ^ 
A- PstI AccI(VY)-A 
( pGEM-T ) 
EK GUSN AF ^ ^ ^ 
^ ligation^ ^ ^ 
A- PstI AccI(VY)-A 
CEK GUSN AF 
^ ^ Ndel PstI 
pGEM T ^ ^ ^ ^ ^ ^ Phasp SP Target gene Phast 
Enzyme digestion/ ( BK ) 
PstI f AccI(VY) 
EK GUSN AF ^ ^ . 
^^^^^Enzyme digestion 
\ ^ ^ ^ ^ Ndel AccI 
\ Ndel PstI 
\ ^ ^ ^ Phasp SP Phast ^^^^ 
\ Target gene ^ 
\ / PBK 
Three-fragment — ^ 
ligation 
Ndel PstI 
Phasp SP Target gene EK GUSN AFVY Phast 
pBK 
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Figure 3-5 (a-c) General schemes for the contruction of GUS fusion constructs 
Target gene represents either MP42 or MP 19 while Phasp 二 phaseolin promoter; SP = 
phaseolin signal peptide; Phast = phaseolin terminator; EK = enterokinase site; GUSN = 
3-glucuronidase without a start codon. 
(c) Modified GUS fusion constructs 
In this part, two chimeric constructs, including target genes MP 19: 1) 
Phas/SP/MP 19-EK: :MGUSN; and 2) Phas/SP/MP42-EK: :MGUSN-AFVY, were 
prepared. 
MGUSN (modified GUS without ATG) was PGR amplified as mentioned in 3.3.2 
to introduce a nucleotide mutation, i.e. Asn-358 to Ser. 
To amplify the MGUSN and MGUSN-AFVY, the following experiments were 
carried out: 
EK::MGUSN: Primers LPEKGus + RmGUS and Primers LmGUS + 
RGUSACC#, in two separate reactions, using pBI121 as 
template for first round PCR 
EK::MGUSN-AFVY: Primers LPEKGus + RmGUS and Primers LmGUS + 
RAAFVYGus, in two separate reactions, using pBI121 as 
template for first round PCR 
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PCR products, 0.5jil from each of the two reaction mixtures was mixed and used as 
template for the second round PCR. The PCR amplified EK::MGUSN and 
EK::MGUSN-AFVY were cloned into pGEM-T vector and excised from the pGEM-T 
vector by PstI and AccI and the following cloning steps were as mentioned in section 
3.3.3b and Figure 3-5c. 
3.4 Transfer of chimeric genes into Agrobacterium binary 
vector 
The chimeric gene constructs (sections 3.3.1 and 3.3.2) were excised by Hindlll 
and ligated into the Agrohacterium-hmdixy vector pBI121 carrying a neomycin 
phosphotransferase II (NPTII) selectable marker and p-glucuronidase (GUS), a 
screenable marker gene. Whereas, Chimeric gene constructs (section 3.3.3b) were 
excised by Hindlll and ligated into the Agrobacte/ium-bimry vector pSUNl carrying a 
neomycin phosphotransferase II (NPTII) selectable marker and a orange fluorescent 
protein (OFP) screenable marker gene. 
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3.4.1 Cloning o f p S U N l 
The GUS gene driven by 35S promoter in pBI121 was replaced by the orange 
fluorescent protein (OFP, Dr. Wan, CUHK). OFP was PCR amplified to introduce a 5, 
BamHI and a 3' S a d site, respectively. This was done by Dr Wan's lab, Biochemistry 
Department. The PCR product was cloned into pGEM-T vector. 
The cloning and construction o fpSUNl was as follow: 
OFP: 5' OFP- Bam HI + 3' OFP- Sad, the PCR amplified step was done by Dr 
Wan's lab in Biochemistry Department 
After cloning into pGEM-T vector, OFP was excised by BamHI and Sad. The 
DNA fragment was then cloned into pBI221. The construct pBI221/35S/OFP was used to 
perform particle bombardment and for orange fluorescent detection. The OFP was 
excised by BamHI and S a d digestion and was cloned into pBI121 by using these enzyme 
sites. 
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Bam HI Sad 
OFP from pBI221 ^ ^ ^ 
，r 
Bam HI Sad 
_ Nos Pro NPTII Noster 35S Pro GUS NOS ter _ 
Hind III 
Figure 3-6 Construction of pSUNl 
The coding sequence of orange fluorescent protein (OFP) was used to replace the GUS 
gene in pBI221. Nos Pro = Nos promoter; Nos ter = Nos terminator; NPTII = neomycin 
phosphotransferase II, a selectable marker amd GUS = P-glucuronidase. 
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(a) MP42 and MP19 constructs 
(1) Phas/MP42 
Phasp MP42 Phast 
(2) Phas/MP19 
Phasp MP 19 Phast 
I I I X X I I I 
_ Nos Pro NPTII Nos ter 35S Pro GUS NoS ter ^ 
Hind III 
(These constructs were cloned by Ng, W. K.) 
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(b) Protein targeting constructs 
(1) Phas/SP/MP42 
Phasp SP MP42 Phast 
(2) Phas/SP/MP42-BP80 
Phasp SP MP42 BP80 Phast 
(3)Phas/SP/MP42-aTIP 
Phasp SP MP42 aTIP Phast 
(4)Phas/SP/MP42-aTIP 
Phasp SP MP42 RMR Phast 
(1) Phas/SP/MP 19 
Phasp SP MP 19 Phast 
(2) Phas/SP/MP 19-BP80 
Phasp SP MP 19 BP80 Phast 
(7)Phas/SP/MP19-aTIP 
Phasp SP MP 19 aTIP Phast 
(8)Phas/SP/MP19-RMR 
Phasp SP MP 19 RMR Phast 
I I I 
^ Nos Pro NPTII Nos ter 35S Pro GUS NOS ter ^ 
， ^ ， 
Hind III 
(c) GUS fusion constructs 
(1)Phas/MP42-EK::GUSN 
Phasp MP42 EK GUSN Phast 
(2) Phas /MP19-EK: :GUSN 
Phasp MP 19 EK GUSN Phast 
(3) Phas/sp/MP42-EK::GUSN 
Phasp SP MP42 EK GUSN Phast 
(4) Phas/sp/MP 19-EK: :GUSN 
Phasp SP MP 19 EK GUSN Phast 
(5) Phas/sp/MP42-EK::GUSN 
Phasp SP MP42 EK GUSN AFVY Phast 
(6) Phas/sp/MP 19-EK: :GUSN 
Phasp SP MP 19 EK GUSN AFVY Phast 
I I I I I I 
_ Nos Pro NPTII Nos ter 35S Pro OFP NOS ter _ 
Hind III 
Figure 3-7 (a-c) Schematic summary of the construction and transfer of chimeric 
genes into Agrobacterium binary vector: pBI121 or pSUNl 
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3.4.2 Primer sequence 
LANM42: 5, AGICTACCATGGCTATCTCTGTG 3， 
LNspM42: 5' CCAIMGCCACTTCACTCGCTATCTCTGTGACTATGG 3， 
LANM 19:5, AGICTACCATGGGAAAGTTCCAAGACATG 3， 
LNspM19: 5' CCATATGCCACTTCACTCGGAAAGTTCCAAGACATGC 3， 
RANM42: 5' CGTATACCATGGTTAGCTGCAGAAGATACCGT 3， 
RASM42: 5' CGTATACGAGCTCGCTGCAGAAGATACCGT 3, 
RPEKM42: 5，CGCTGCAGGC^CTTGTCGTCGTCGTC^GCTACAGAAGATACCGTCGAA 3, 
RAAFVYGus: 5’ AGTATACAAATGCTTGTTTGCCTCCCTGCTGC 3’ 
LPEKGus: 5' TTCTGCAGCIGACGACGACGACAAC^TTACGTCCTGTAGAAACCCCA 3, 
LmGUS: 5' CGGCTTTAGCCTCTCTTTAG 3’ 
RmGUS: 5, CTAAAGAGAGGCTAAAGCCG 3' 
3'RGUSACC#: 5' GGTATACTCATTGTTTGCCTCCCTGCTGC 3' 
Acc 491-L: 5, CGTATACACTAAAACTGCCAGTCAGGC 3， 
Acc 727-L: 5' CGTATACTGGTTGATCCCAAGTTTTGAG 3, 
RAaTIP: 5' CGTATACTCAGTAATCTTCAGTTGCCAAAG 3, 
RABP-80: 5' CGTATACTCAACCTCTTTGATGATTGACA 3, 
RARMR: 5, CGTATACTCAACAGTCTGGAAGCGAGTTTG 3’ 
Figure 3-8 Sequence of primers used in the chimeric gene construction 
A total of 14 primer sequences were synthesized for the amplification and cloning. AccI 
site: underlined; PstI site: grey solid boxed ； EK site: boxed; AFVY: bolded. 
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3.5 Bacterial strains 
E, coli DH5a was used for chimeric gene construction. Agrobacterium tumefaciens 
GV3101/pMP90 (Koncz and Schell, 1986) and LBA4404/pAL4404 (Hoekema et al., 
1983) were employed in Arabidopsis and tobacco transformation, respectively. 
3.6 Particle bombardment 
3.6.1 Plant materials 
The cotyledons of developing fresh snow bean, from local store, were removed 
from the bean pods and used for particle bombardment. 
3.6.2 Microcarrier Preparation and Coating DNA onto microcarrier 
For microcarrier preparation, 40mg gold particles with diameter of 1 阿 were 
weighed and washed with 0.8ml freshly prepared 70% ethanol. After, the mixture was 
vortexed for 3-5 minutes. Then it was allowed to stand for 15 minutes and pelleted by 
spinning for 5 seconds. The supernatant was discarded and the pellet was washed three 
times with 0.8ml sterile distilled water, 1 minute each, then settled for 1 minute by 2 
seconds brief centrifugation. Finally, 50% glycerol was added to bring the microparticle 
concentration to 60mg/ml. 
For bombardment, 33.3|al (2mg) microcarriers was used and 3.33|al plasmid DNA 
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(l|ag尔 1), 33.3|al CaCli (2.5M) and 13.3^1 spermidine (O.IM) were added into the 
microcarriers while vortexing vigorously for 2-3 minutes. Then the microcarriers were 
allowed to settle for 1 minute and spun for 2 seconds. The supernatant was discarded and 
93.3|dl 70% ethanol was added and discarded without disturbing the pellet. Then, 93.3|LI1 
100% ethanol was added and then removed without disturbing the pellet. Finally, the 
pellet was resuspended in 32|LI1 100% ethanol thoroughly by vortexing at low speed for 
2-3 seconds. The preparation was sufficient for 4 bombardments. For each bombardment, 
6]i\ aliquot was transferred to the center of a macrocarrier and allowed to air dry before 
bombardment. The conditions for bombardment were listed in Table 3-1. 
The cotyledons used for the experiment were placed onto 0.8% bactoagar and 
bombarded using the biolistic PDS-lOOO/He system according to procedures described by 
Sanford (Sanford, 1987). After the bombardment, the cotyledons were incubated for 
20-24 hours at room temperature and GUS staining was performed afterward. 
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Table 3-1: Parameters used in particle bombardment 
Parameters Conditions 
Micromarriers 1 )im gold 
Vacuum 27 inches Hg 
Helium pressure 1,100 psi 
Target distance 9cm 
3.6.3 GUS assay 
GUS assay was done by following standard protocol (Jefferson, 1987). Snow 
beans received particle bombardment were placed into a falcon tube containing the GUS 
staining solution (lOOmM Na-phosphate buffer, pH7.0, 0.1% Triton X-100, ImM EDTA, 
0.5mM K3Fe(CN)6, K4.Fe(CN)6 and 0.5mg/mL X-gluc) and incubated at 37°C. After 
overnight incubation, 70% ethanol was added to remove chlorophyll. Then, relative 
intensities of blue-dot development among the cotyledons in each individual test were 
recorded under the observation of dissection microscope. 
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3.7 Transgenic expression in Arabidopsis thaliana 
3.7.1 Plant materials 
Arabidopsis thaliana ecotype Columbia-0 was used in the study. Surface 
sterilization of the seeds was performed by shaking the seeds in Clorox solution (sodium 
hypochlorite, 5.25%) for 3 minutes followed by 3 minutes washing in sterilized distilled 
water for 3 times. Then, the sterilized seeds were plated onto MS medium (4.3g/L MS 
salts (Gibco), 2% sucrose, ix B5 vitamin, 0.8% bacto-agar, pH5.7). The seeds were 
firstly placed in cold chamber at 4°C for 2 days and then in 22°C growth chamber with a 
light (daylight 4000k lux) & dark cycle of 16 hours and 8 hours, respectively. The 
geminated plantlets were collected and further grown on a new MS medium for 2-3 
weeks before being transferred into soil. 
3.7.2 Agrobacterium transformation 
This was done by Ng, W. K. (Ng, 2001) with standard procedures. 
3.7.3 Vacuum infiltration Arabidposis transformation 
The method was based on Bechtold et al (1993) with modification by Lam H.M. 
(Personal communication, Chinese University of Hong Kong). A single colony of 
GV3101/pMP90 containing the target gene (section 3.3.1) was cultured with shaking in 5 
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ml LB medium (lOg/L NaCl, lOg/L bacto-tryptone and 5g/L yeast extract) containing 
50mg/l rifampicin, kanamycin and 25mg/L gentamycin at 28�C. On the second day, 1ml 
starter culture was sub-cultured in 500ml YEP (lOg/L bacto-peptone, lOg/L yeast extract 
and 5g/L NaCl) medium containing the same antibiotics mentioned above until OD500 > 2. 
The culture was then centrifuged at TOOOrpm for 10 minutes and resuspended in IL 
infiltration medium (2.2g/L MS salts, Ix B5 vitamins, 50g.L sucrose, 0.5g/L MES, 
0.044JLIM benzy 1 aminopurine, and 0.02% silwetxM L-77, pH5.7). 
The resuspended cultured was then poured into a IL beaker and placed into a 
vacuum chamber. The plants, as mentioned in 3.6.1, were then inverted with the silique 
soaking into the bacterial solution. Vacuum was applied and the plants were allowed to 
stay under vacuum for 10 minutes with bubbles starting to form. At the end of the 
treatment, vacuum was released and the plants were drained briefly. Then the plants were 
set upright using the hollow cylinders made by transparencies and they were allowed to 
grow for seed collection. The seeds so harvested are the Ri seeds. 
3.7.4 Selection of successful transformants 
Surface sterilization of the R\ seeds (100|LI1 roughly 2500 seeds) was performed 
with a procedure which was mentioned in 3.6.1 except that the seeds were plated onto the 
MS medium containing 50mg/L kanamycin. The incubation and treatment of the seeds 
were the same as mentioned in section 3.6.1 and the successful transformants which grew 
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into green plantlets were selected and further grew on a new MS medium for 2-3 weeks 
before transfering into soil. To prevent cross fertilization, the individual transformant was 
wrapped by hollow cylinder made of overhead transparency. The seeds so harvested were 
the R2 seeds. 
3.7.5 Selection for homozygous plants 
About 50 R2 seeds were sterilized as mentioned in 3.6.1 and plated on a selection 
medium containing kanamycin. The Ri plants showing 3 to 1 survival to death ratio in a 
Chi-square analysis were grown for seed collection (R3). A further screening on the R3 
seed was carried out and those survived in the selection medium were selected as 
homozygous line for further expression analysis. 
3-8 Transgenic expression in tobacco 
3.8.1 Plant materials 
Leaves of about 1 month old wild type tobacco {Nicotiana tabacum L. cv 
Xanthin. nc) grown in a 24°C growth chamber with a 16 hour photoperiod were used for 
.4gro^(2C?ermm-mediated transformation. 
51 
3.8.2 Agrobacterium transformation 
The Freeze-frost method was used for transformation of the pBIlll vector carrying 
chimeric gene constructs into Agrobacterium tumefaciens LBA4404/pAL4404. 
3.8.2.1 Preparation of Agrobacterium tumefaciens LBA4404/pAL4404 competent 
cells 
On day 1, 10ml LB containing streptomycin (25mg/L) and Agrobacterium 
LBA4404/pAL4404 starter culture were grown at 28°C for 2 days. On day 3, 400|LI1 of the 
Agrobacterium culture was subcultured into 40ml LB and allowed to grow for 5 hours at 
28°C. Then, the Agrobacterium cells was spun down at 4800rpm for 5 min and washed 
with 4ml sterilized distilled water. This was followed by a spin and the cells were 
resuspended in 4ml LB with aliquot of 500jil. 
Transformation 
First, an aliquot of 500|LI1 A. tumefaciens LBA4404/pAL4404 competent cells was 
thrawn on ice with the addition of 5|li1 plasmids which contained the chimeric gene 
constructs for 5 minutes. Then, the mixture was incubated with liquid nitrogen for 5 
minutes followed by an incubation at 37°C for 5 minutes. After, one ml LB was added 
and the culture was incubated at 28 °C for 4 hours. Finally, the culture was spun at 5000 
rpm, resuspended in 100|LI1 LB, and spreaded on a agar plate with streptomycin (25mg/L) 
52 
and kanamycin (50mg/L). Colonies which developed on the plate at 28°C after 36 hours 
were selected for subsequent mini-prep (Promega kit) and PCR checking (section 3.3.2). 
3.8.3 Leaf discs method for tobacco transformation 
A single colony of Agrobacterium tumefaciens LBA4404 containing the target gene 
(3.3.2 and 3.3.3b) was cultured in 3 ml LB medium containing 50 mg/1 kanamycin and 25 
mg/1 streptomycin at 28 °C with shaking until OD620�1 . The bacterial culture was spun 
down and resuspended in inoculation medium. The wash was repeated for 2 times and 
finally the cells were resuspended in 3 ml MS liquid medium. Leaves from the wild type 
/-J  
tobacco were cut into small pieces ( � 0 . 7 x 0 . 7 cm ) with razor blade. The cut leaf explants 
were then submerged in diluted (1:10) Agrobacterium culture, 18 ml inoculation medium 
with 2 ml resuspended Agrobacterium culture, for 10 minutes. After blotting dry on 
sterile filter paper, the explants were placed on co-cultivation medium. 
After 4 days co-cultivation at 24 with a 16 hour photoperiod, leaf explants were 
transferred onto shooting medium and incubated in growth chamber under the same 
conditions as above for callus induction and shoot formation. The leaf explants were 
transferred to fresh medium every 16-20 days. The regenerated shoots (1 to 3 cm in 
height) were cut off and inserted into rooting medium for rooting. Finally, the regenerated 
tobaccos were transferred to soil and grown in certified greenhouse or experimental field. 
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Table 3-2: Composition of tissue culture media 
MS liquid Co-cultivation Shooting Rooting 
medium medium medium medium 
MS salts g/L 4.3 4.3 4.3 4.3 
(Gibco)  
l x B 5 vitamin + + + + 
Sucrose g/1 20 20 20 20 
BAmg/1 1 1 1 -
NAAmg/1 0.1 0.1 0.1 -
Phytagel mg/1 - 0.9 0.9 0.9 
Kanamycin - - 100 50 
mg/1  
Carbenicilin - - 300 200 
mg/1  
(BA = N6-benzyladenine, NAA = Naphthaleneacetic acid and all medium is at pH 5.7) 
3.8.4 GUS staining 
GUS staining was done by following a standard protocol (Jefferson, 1987). 
Regenerated tobacco leaf disc was placed into an eppendorf tube containing the GUS 
staining solution (lOOmM Na-phosphate buffer, pH7.0, 0.1% Triton X-100, ImM EDTA, 
0.5mM K3Fe(CN)6, K4.Fe(CN)6 and 0.5mg/mL X-gluc) and incubated at 37�C. After 
overnight incubation, the GUS staining solution was removed and 70% ethanol was 
added to remove chlorophyll. The stained plant materials were placed in 50% glycerol for 
long time storage. 
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3.9 DNA analysis 
3.9.1 Genomic DNA extraction 
Genomic DNA was isolated from Arabidopsis or tobacco leaves using the CTAB 
protocol (Doyle et al., 1990) and was suspended in 50 jul ddHaO. DNA concentrations 
were determined with a spectrophotometer by OD260 measurement and were checked by 
gel electrophoresis in a 1% agarose/ TAE (0.04M Tris-acetate and 1 |LXM EDTA) gel. 
3.9.2 Genomic PCR 
By using genomic DNA as template, PCR as mentioned in 3.3.2 was performed to 
detect the presence of the transgene in the regenerated tobacco except that a 25|LI1 reaction 
mixture containing 0.5|Lig genomic DNA was used. Then, 5\i\ PCR products were then 
taken for agarose/ TAE gel electrophoresis. 
3.9.3 Southern Blot 
Genomic DNA (15 |Lig) was digested overnight with BamHI, separated on 1% 
agarose/ TAE gel, at 60 V for 4 hours, and then transferred to nylon membrane (positively 
charged, Roche) using VacuGeneXL Vacuum blotting System (Pharmacia Biotech). 
Hybridization and detection was performed according to the method described in the DIG 
Nucleic Acid Detection Kit (Roche) with single strand DIG-labeled DNA probes 
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(modified MSPI42 or 19) which was prepared using DIG DNA labeling Kit (Roche) by 
PCR amplification using LANm42 or LANml9 and DIG-labeled dUTPs. 
3.10 RNA analysis 
3.10.1 RNA extraction 
Total RNA was extracted from the developing silique of Arabidopsis and developing 
toabacco seeds by the method as described by Altenbach et al. (1989). The concentration 
and the quality of the extracted RNA was checked by a spectrophotometer and 
electrophoresis in 1% agarose/ formaldehyde gel. 
3.10.2 Northern Blot 
Total silique RNA and tobacco RNA, with 6 |ig was first separated in 1 % agarose/ 
formaldehyde gel and then transferred to nylon membrane (positively charged, Roche) 
using VacuGeneXL Vacuum blotting System (Pharmacia Biotech). Hybridization and 
detection was performed according to the method described in the DIG Nucleic Acid 
Detection Kit (Roche) with single strand DIG-labeled DNA probes (modified MSP 142 or 
19) . 
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3.11 Protein analysis 
3.11.1 Protein extraction 
Seed total protein extraction 
Total seed protein was extracted from 0.04g mature dry seeds by grinding the seeds 
into powder and mixing with 0.4ml protein extraction buffer [50mM Tris-HCl pH 8.0, 
O.IM NaCl, lOmM EDTA and 1% SDS]. The homogenate was then centrifuged at 14,000 
rpm for 15 minutes at 4°C. The clear supernatant was transferred to a new eppendorf tube 
and saved as total protein extract. The step of centrifugation was repeated once as this 
may help to prevent lipid contamination. The protein concentration was determined by 
the Lowry method using the DC protein assay (Bio-Rad) with bovine serum albumin 
(BSA) as a standard. 
Protein from soluble and membrane fractions 
Cell soluble protein (CS) was extracted from 0.04g mature dry seeds by grinding the 
seeds into powder and mixing with 0.5ml protein extraction buffer [50mM Tris-HCl pH 
8.0, O.IM NaCl and lOmM EDTA]. The homogenate was then centrifuged at 14,000 rpm 
for 15 minutes at 4°C. The clear supernatant was transferred to a new eppendorf tube and 
saved as seed soluble protein. 0.3ml protein extraction buffer [50mM Tris-HCl pH 8.0, 
O.IM NaCl, lOmM EDTA and 1% SDS] was added to the pellet and mixed. The 
homogenate was then centrifuged at 14,000 rpm for 15 minutes at 4�C. The clear 
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supernatant was transferred to a new eppendorf tube and saved as seed insoluble cell 
membrane protein (CM). The protein concentration was determined by the Lowry 
method using the DC protein assay (Bio-Rad) with bovine serum albumin (BSA) as a 
standard. 
3.11.2 Western Blot 
For tricine-SDS-PAGE (Laemmli, 1970), total seed protein (50 jig) was mixed with 
equal volume of 2x sample loading buffer (0.5M Tris-HCl, pH6.8, 10% SDS, 0.2M 
EDTA, trace amount bromophenol blue) with or without (3-mercaptoethanol (4%). For 
samples with p-mercaptoethanol, they were further incubated at 99°C for 10 minutes. All 
samples were separated by 16.5% tricine-SDS-PAGE. After electrophoresis, the gel was 
either stained in Coomassie blue solution (1 g/L Coomassie brilliant blue G-250, 1% 
methanol) or transferred to membrane for immuno-detection. Stained gel was destained 
in destaining solution (methanol : 100% glacial acetic acid : water, 20 : 6 : 55). 
3.11.3 Western blot analysis 
After tricine-SDS-PAGE, protein samples were blotted onto PVDF membrane 
(Bio-Rad) using mini-Trans-blot system (BioRad) as described in the user manual. 
Electro-transfer was performed at constant voltage (100 V) for 60 minutes in transfer 
buffer (48mM Tris, 39mM Glycine, 20% methanol). The efficiency of the transfer was 
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monitored by staining the transferred gel as in section 3.5.9. 
The transferred membrane was first blocked in 0.2% blocking solution (IX TBS, 
0.2% AURORA blocking reagent, 0.1% Tween20) at room temperature for 1 hour and 
was then incubated with 3.3 )il of anti-MSPUi serum as primary antibody (Lau, 2003) in 
10 ml of 0.2% blocking solution at room temperature for 1 hour. After washing the 
membrane three times in 0.2% blocking solution, the membrane was incubated in 0.2% 
blocking solution containing alkaline phosphatase (AP)-conjugated goat anti-rabbit 
immuno-globulin G (Bio-Rad) at a 1:3000 dilution for 1 hour. The membrane was further 
washed by 0.2% blocking solution, and the reactive protein bands were detected by 
incubation with the enzyme colour substrate NBT-BCIP (Bio-Rad). 
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Chapter 4 Results 
4.1 Transient expression of MSPI42 and MSPI19 
4.1.1 Construction of the GUS fusion constructs 
Four Gus fusion constructs, pTZ/Phas/P42::GUSN, pTZ/Phas/MP42::GUSN, 
pTZ/Phas/P19::GUSN and pTZ/Phas/MP19::GUSN were tested for transient 
expression by particle bombardment with a positive control, pTZ/Phas/GUS and a 
negative control: pTZ/Phas/GUSN. GUSN without a start codon was used for the 
fusion constructs except for the positive control. 
Schematic diagrams of the constructs are shown in Figure 4.1.1-1 and 
restriction maps for the construction of pTZ/Phas/MP 19:: GUSN is shown in Figure 
4.1.1-2. In addition, DNA sequencing was performed to further confirmed the fidelity 
of the constructs (data not shown). 
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(a) Phasp GUS Phast pTZ 
(b) Phasp GUSN Phast pTZ 
(c) Phasp P42 GUSN Phast pTZ 
(d) Phasp MP42 GUSN Phast pTZ 
(e) Phasp PI9 GUSN Phast pTZ 
(f) Phasp MP 19 GUSN Phast pTZ 
Figure 4.1.1-1 (a-f) GUS fusion constructs used in the transient assay 
(a) pTZ/Phas/GUSATG, positive control; (b) pTZ/Phas/GUSN, negative control, (c) 
pTZ/Phas/P42::GUSN, unmodified P42; (d) pTZ/Phas/MP42::GUSN, modified P42; 
(e) pTZ/Phas/P19::GUSN, unmodified P19; (f) pTZ/Phas/MP 19::GUSN, modified 
P19 
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(a) ^ �k b • 
^ -3.1 kb ^ 
^ -2.1 kb ^ 
Hindlll AccI PstI AccI PstI ,HindIII 
Phasp MP 19 GUSN Phast pTZ 
M AccI PstI Hindlll 
(b) M M M H ^ ^ M 
^ r 4.5kb 
; �3 . 1 k b 
. _�2.1kb 
Figure 4.1.1-2 Construction of the pTZ/Phas/MP19::GUSN 
(a) Structure of the pTZ/phas/MP 19::GUSN showing the position of different 
enzyme sites and the fragment sizes, (b) Restriction digestion of the 
recombinant plasmids by different enzymes as indicated. The arrows indicate 
the expected sizes of the bands. Key: M: 1 Kb plus DNA ladder (Invitrogen). 
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4.1.2 Particle Bombardment 
Totally, Four bombardment tests were performed. The number of snow bean 
cotyledons showing blue dot development with different relative intensities was 
counted. The results were shown in Table 4.1.2-1 a-d and bar charts of Figure 4.1.2-1 
a-d. Photographs were taken to illustrate the different levels of blue dot development 
by the six constructs in Figure 4.1.2-2 a-f. 
All cotyledons of positive control gave blue dot development with more or 
less even distribution but at all intensity levels (from 5+ to 1+). The level of 
expression by the modified genes was greater than that of the unmodified ones 
because, firstly, over 80% of the cotyledons bombarded with pTZ/Phas/MP42::GUSN 
gave positive results including a few gave distinctly high intensity, but no blue dot 
was found in the cotyledons of pTZ/Phas/P42::GUSN. Secondly, greater number of 
cotyledons of pTZ/Phas/MP 19:: GUSN gave blue dot development than the 
pTZ/Phas/P19::GUSN. 
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Table 4.1.2-1 a-d: Transient expression of MSPl as GUS fusion in bean 
cotyledons 
Tables a to d show the results of Test 1 to 4, respectively. Cotyledons shown one or 
more blue dots were regarded as positive results. Key: + shows the relative intensity 
of blue dots (5+, maximum) 
(a)  
Constructs Dish Positive Results Negative Total 
_No. 5+ 4+ 3+ 2+ 1+ Results 
pTZ/Phas/GUS 1 2 3 5 3 0 16 
2 1 3 4 2 5 0 15 
pTZ/Phas/GUSN 1 0 0 0 0 0 16 16 
2 0 0 0 0 _ 0 16 16 
pTZ/Phas/P42::GUSN 1 0 0 0 0 0 16 16 
2 0 0 0 _ 0 0 15 15 
pTZ/Phas/MP42: :GUSN 1 0 1 0 5 8 2 16  
| 2 | l | 2 | 3 | l | 5 | 4 16 
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(b) Constructs Dish Positive Results Negative Total 
No. 5+ 4+ 3+ 2+ 1+ Results 
pTZ/Phas/GUS 1 2 3 5 3 0 16 
2 4 2 ^ 6 1 0 16 
pTZ/Phas/GUSN 1 ~ Q Q Q ~ ~ Q ~ ~ Q 15 “ 15 
2 0 0 0 _ _ 0 _ 0 15 15 
pTZ/Phas/P42::GUSN 1 0 0 0 0 0 15 15 
2 0 0 0 _ _ 0 0 _ 15 15 
pTZ/Phas/P19::GUSN 1 ~ 0 1 0 2 7 5 15 
2 0 0 1 1 11 3 15 
pTZ/Phas/MP42: :GUSN 1 1 3 2 0 8 1 ^ 1 5 
2 1 2 1 4 4 15 
pTZ/Phas/MP19::GUSN 1 0 4 1 3 7 0 1 5 ^ 
2 2 2 3 4 5 0 16 
(c) 
Constructs Dish Positive Results Negative Total 
No. 5+ 4+ 3+ 2+ 1+ Results 
pTZ/Phas/GUS 1 2 1 3 4 5 0 15 
2 2 1 2 4 5 1 15 
pTZ/Phas/GUSN 1 Q 0 0 0 0 _ 15 15 
2 0 0 0 0 0 15 15 
pTZ/Phas/P 19::GUSN 1 0 2 0 2 7 4 15 
2 0 0 1 4__ 9 1 15 
pTZ/Phas/MP 19:: GUSN 1 3 4 3 ]__ 2 15 
2 3 2 4 3 2 1 15 
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(d) 
Constructs Dish Positive Results Negative Total 
No. 5+ 4+ 3+ 2+ 1+ Results 
pTZ/Phas/GUS 1 ~ ~ ^ 3 3 ~ 2 ~ 0 1 5 ^ 
2 4 3 _ 3 4 1 0 15 
pTZ/Phas/GUSN 1 ~ Q 0 0 0 0 16 16 
2 0 0 _ 0 0 0 15 15 
pTZ/Phas/P42::GUSN 1 0 ~ 0 0 0 0 15 1 5 ^ 
2 0 0 0 _ _ 0 0 15 15 
pTZ/Phas/P19::GUSN 1 1 0 1 0 9 4 1 5 ^ 
2 2 1 1 2 ^ 4 15 
pTZ/Phas/MP42::GUSN 1 2 2 1 5 4 1 15 
2 1 1 2 3 6 2 15 
pTZ/Phas/MP19::GUSN 1 1 3 1 6 1 3 ^ 1 5 
I 2 I 1 3 1 7 1 16 
In summary, pTZ/Phas/P19::GUSN, pTZ/Phas/MP42::GUSN and 
pTZ/Phas/MP 19:: GUSN can be expressed while the modified shorter sequence 
pTZ/Phas/MP 19:: GUSN give better expression. 
66 
(a) 
Test 1: Results of Particle Bombardment 
= � f ^ B n 
GATG GN P42 MP42 ^  
Construct 
(b) 
Test 2: Results of Particle Bombardment 
3〇• ： [j O J[L_ 曰 Negative Result 
Number�fBean 2。<一]|^; J ^ J j ^ ’ 二 ： 
GATG GN P42 P19 MP42 MP19 IH^   
Construct 
(C) 
Test 3: Results of Particle Bombardment 
3-yJ _ i i i 
p i g l m j 
25- “ 一 _、 _ j__ J W j I 0 Negative Result 
Number of Bean 二 d ； 一 一；-jt ~ H ！一 
丨;qrtH —g _ J — - H 
GATG GN P42 P19 MP42 MP19 L^  
Construct 
(d) 
Test 4: Results of Particle Bombardment 
「“ Ij El Negative Result 
Number� fBean |—— j||||||—— *— 02+ 
GATG GN P19 MP19  
Construct 
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Figure 4.1.2-1 a-d Particle bombardment and transient expression of MSPl GUS 
fusions 
Number of cotyledons showing different relative intensities are shown in bar charts in 
different colours as indicated. Key: GATG: Phas/GUS (GUS with ATG, a positive 
control); GN: Phas/GUSN (GUS without ATG, a negative control); P42: 
Phas/P42::GUSN; MP42: Phas/MP42::GUSN; and P19: Phas/P19::GUSN; MP 19: 
Phas/MP19::GUSN 
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L 動 参 
Figure 4.1.2-2 a-f. Photographs illustrating the different levels of blue dot 
development in particle bombardment 
(a) pTZ/Phas/GUSATG, positive control; (b) pTZ/Phas/GUSN, negative control; (c) 
pTZ/Phas/P42::GUSN, unmodified P42; (d) pTZ/Phas/MP42::GUSN, modified P42; 
(e) pTZ/Phas/P19::GUSN, unmodified P19; (f) pTZ/Phas/MP19::GUSN, modified 
P19 
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4.2 Transgenic analysis of MSPI42 and MSPI19 expression 
4.2.1 MSPI42 and MSPl 19 constructs and transformation 
MSPl42 (MP42) and MSPl 19 (MP 19) were used to construct chimeric genes 
under the control of phaseolin promoter and terminator. 
Diagrams of the constructs are shown in Figure 4.2.1-1 
(a) Phasp MP42 Phast pBI121 
(b) Phasp MP 19 Phast pBI121 
Figure 4.2.1-1 MSPI42 and MSPI19 chimeric constructs in vector pBI121. 
(a) Phas/MP42 and (b) Phas/MP19. Phasp: Phaseolin promoter; Phast: 
Phaseolin terminator. 
The two chimeric constructs pBI/Phas/MP42 and pBI/Phas/MP19 were 
transformed into A. tumefaciens GV3101/pMP90 for Arabidopsis transformation. 
Construct diagrams are shown in Figure 4.2.1-1 
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4.2.2 Selection of transgenic plants 
After Arabidopsis transformation, first generation transgenic plants (Rl) 
harboring the two chimeric gene constructs were obtained through kanamycin 
medium selection. 
To select heterozygous lines, the self-fertilizied seeds (R2) of the Rl 
transgenic plants, based on the Mendel's law for monohybrid cross, were further 
screened for 3:1 survival to dead ratio on kanamycin medium and Chi-square 
statistical test was used to determine the credibility of the survival ratio. 
Seven out of fourteen lines of R2 seeds of MSPI42 (Table 4.2.2-la) and eleven 
out of twenty-four lines of R2 seeds of MSPl 19 (Table 4.2.2-lb) were screened and 
identified as heterozygous. 
Homozygous lines (R3) of the two chimeric constructs were selected by 
screening the fertilized seeds of the R2 plants on kanamycin medium. All the seeds of 
homozygous lines survived on the selection medium and the selected homozygous 
lines were used in subsequent molecular analysis (Table 4.2.2-2). 
Sixteen homozygous lines were collected for MSPl42 and eight lines for 
MSPl 19. 
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Table 4.2.2-1 a and b: Selection of R2 Arabidopsis lines by Chi-square analysis 
R2 progenies giving roughly 3 to 1 survival to death ratio were assumed to be 
heterozygous lines. The validity of data was analyzed using Chi-square test at P value 
of 0.05 (chi-square = 3.84). “+” means P value > 0.05 (chi-square < 3.84) indicating 
that the difference between the observed and predicted results was insignificant and 
thus selected. 
(a) pTZ/Phas/MP42 
Plant Total no. No. survived No. died Chi-square 
1. 1 81 47 34 -
1.2 96 96 0 -
2.2 126 91 35 + 
2.3 101 79 22 + 
2.4 96 84 12 -
3.3 95 49 46 -
4.1 102 19 83 -
4.2 105 78 27 -
5. 1 m ^ 19 + 
5.2 111 m 1 -
5.3 108 81 27 + 
6.3 108 82 26 + 
7.7 115 93 22 + 
8.1 89 68 21 + 
Key: “+,，stands for positive result; “-，，stands for negative result 
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(b) pTZ/Phas/MP19 
Plant Total no. No. survived No. died Chi-square 
1. 1 n i 79 38 + 
1. 2 93 73 一 20 + 
1-3 ^ 38 46 -
1.4 m 46 ^ -
2.1 106 77 ^ + 
2. 2 no 89 21 + 
2. 3 107 92 15 -
2. 4 103 88 15 -
2. 5 127 99 28 + 
2. 6 105 49 56 -
3.1 98 59 39 -
3.2 90 62 28 + 
3.3 95 70 25 + 
3. 4 ^ 68 -
3.5 96 64 32 -
5.1 108 106 2 -
5.2 102 15 ^ -
5.3 84 64 20 + 
5.4 105 89 16 -
5.5 107 84 23 + 
9.2 104 89 15 -
9.3 95 65 30 + 
10.1 102 73 29 + 
10.2 88 I 47 I 41 I - 一 
Key: “+，，stands for positive result; “-，，stands for negative result 
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Table 4.2.2-2: Selection of homozygous transgenic R3 Arabidopsis lines 
R3 transgenic lines homozygous in gene insertion all survived antibiotic selection 
Homozygous transgenic R3 Arabidopsis 


















4.2.3 Southern analysis 
Southern analysis was carried out to confirm the integration of the transgene in 
the plant genome. The copy number of the integrated transgene was estimated through 
the blotting. For this analysis, the genomic DNA of the homozygous lines was 
extracted and digested with BamHI which cuts only one time on the T-DNA vector 
backbone, but not the transgene. 
The leaves of sixteen homozygous lines of MSPl42 and eight of MSPl 19 were 
collected for genomic DNA extraction and Southern blot analysis using MSPl42 and 
MSPl 19 as a probe, respectively. 
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Figure 4.2.3-1 Southern analysis of Phas/MP42 transgenic Arabidopsis 
(a) Genomic DNA (15|ag) was digested with BamHI and separated by gel 
electrophoresis, (b) The resolved DNA was blotted onto a nylon membrane for 
hybridization. Key: WT: wild type Col-o; M: DNA Molecular Weight Marker VII, 
DIG-labeled (Roche). 1: transgenic line 2.3.1; 2: 2.3.2; 3: 2.3.3; 4: 2.3.4; 5: 2.3.5; 6: 
2.3.11; 7: 5.3.3; 8: 5.3.8; 9: 6.3.1; 10: 6.3.2; 11: 7.7.3; 12: 7.7.4; 13: 7.7.7; 14: 8.1.3; 
15: 8.1.7; and 16: 8.1.12. The estimated copy number of the transgene in each line 
was also shown in (b). 
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4.2.3 Southern analysis 
Northern blotting with total silique RNA was carried out to study the transgene 
expression at transcriptional level (Figures 4.2.4-1 and 4.2.4-2). MSPl transcript of 
most of the transgenic lines (14 out of 16) was detected with the expacted band size, 
1.2 Kb for the MSPl42 construct and of eight transgenic lines with the expected size, 
0.3 Kb for the MSPl 19 construct. 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 WT �• m i 11 i f f ^ ^ H 
HiL^ fifc^ iLiy 以 、 1 1 •：：霧：‘域：遍 
(b) M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 WT 
2.37kb 一 
‘ — . _ _ " . _ - : ” : . 一 . 2 K b 
0.24kb _ _ _ ^ ^ 1 1 _ _ 1 _ 囊 
(C) 1.1Kb 1.2Kb 1.3Kb 
Phasp MP42 Phast 
Figure 4.2.4-1 Northern analysis of MP42 the transgenic Arabidopsis, 
(a) Total siliques RNA (SiLig/lane) was resolved in 1% RNA denaturating gel; (b) The 
resolved RNA was blotted onto a nylon membrane for hybridization and detection; 
and (c) Diagram showing the size of the chimeric gene fragments. Key: M: 
0.24-9.5Kb RNA ladder (Invitrogen); WT: Wild type; 1: Transgenic line 2.3.1; 2: 
2.3.2; 3: 2.3.3; 4: 2.3.4; 5: 2.3.5; 6: 2.3.11; 7: 5.3.3; 8: 5.3.8; 9: 6.3.1; 10: 6.3.2; 11: 
7.7.3; 12: 7.7.4; 13: 7.7.7; 14: 8.1.3; 15: 8.1.7; and 16: 8.1.12 
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(a) 
1 2 3 4 5 6 7 8 WT 
；；凝錢：丨__ 翁资 lil 丨:_画1_1____ 丨頻 __ 丨錢 丨缀 錢 
o.24kb - B m '仏’，:"•、 — o i b 
i_i難讀讓___瞧議議___難_____讓__顯_謹__難_____纖______|___；麵___纖|議__ 
(b) 
1.1Kb 1.1Kb 1.1Kb 
Phasp MP 19 Phast 
Figure 4.2.4-2 Northern analysis of the MP19 transgenic Arabidopsis. 
(a) The resolved RNA was blotted onto a nylon membrane for hybridization and 
detection and (b) Diagram showing the size of the chimeric gene fragments. Key: M: 
0.24-9.5Kb RNA ladder (Invitrogen); WT: Wild type; 1: transgenic line 2.5.2; 2: 
3.3.1; 3:3.3.2; 4:3.3.3; 5: 5.3.6; 6: 9.3.2; 7: 10.L4;and8: 10.1.8 
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4.2.3 Southern analysis 
Recombinant protein was detected by western blotting analysis. For this 
detection, all of the transgenic were shown to give positive signal in the Northern 
analysis (Figures 4.2.4-1 and 4.2.4-2). The expected sizes of the MSPl42and MSPl 19 
recombinant proteins are 42Kda and 19Kda, respectively. However, no comparable 
protein band was detected for both the MSPI42 and MSPl 19 constructs (Figures 
4.2.5-1 and 4.2.5-2). 
MP42 lines 
+ve control marker 8.2.8 8.2.4 WT 
藝 < "42kDa 
-：> 
Figure 4.2.5-1 Western analysis of the MP42 transgenic Arabidopsis 
Total seed soluble protein (50/xg/lane) resolved in 12.5% SDS-PAGE without 
3-mercaptoethanol was blotted onto PVDF membrane (Bio-Rad) and reacted with 
monoclonal antibody MAb5.2 as primary antibody and alkaline phosphatase 
conjugated anti-mouse IgG as secondary antibody. Protein sample from MP42-AFVY 
was included as a positive control. 
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MP 19 lines 
M W T M 2.5.2 3.3.1 3.3.2 3.3.3 5.3.6 9.3.2 10.1.4 10.1.8 
^ _ 19kDa 
Figure 4.2.5-2 Western analysis of the MP19 transgenic Arabidopsis 
Total seed soluble proteins (SO/ig/lane) resolved in 12.5% SDS-PAGE without 
3-mercaptoethanol was blotted onto PVDF membrane (Bio-Rad) and reacted with 
monoclonal antibody MAb5.2 as primary antibody and alkaline phosphatase 
conjugated anti-mouse IgG as secondary antibody. Protein sample from denatured 
LRP/MP42 (line 1.2.8) was included as a positive control with a calculated MW of 
6L6kDa. The arrow shows the position of the expected MSPl 19 protein 
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4.3 Expression of the protein-targeting and GUS-fused 
modified MSPl constructs 
4.3.1 Construction of the fusion constructs 
(A) Protein-targeting constructs 
In an attempt to target the MP42 and MP 19 to protein storage vacuole for 
accumulation and deposit, three targeting sequences, BP-80, a-TIP and RMR were 
introduced to their C-terminal ends. All these constructs were driven by the phaseolin 
promoter with its signal sequence. 
Eight chimeric gene constructs including pBI/Phas/SP/MP42, 
pBI/Phas/SP/MP 19, pBI/Phas/SP/MP42-BP80, pBI/Phas/SP/MP 19-BP80, 
pBI/Phas/SP/MP42-a-TIP, pBI/Phas/SP/MP 19-aTIP, pBI/Phas/SP/MP42-RMR and 
pBI/Phas/SP/MP 19-RMR were thus constructed (Figure 4.3.1-1) and introduced into 
LBA4404 for Tobacco transformation. 
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(a) — Phasp SP MP42 Phast pBI121 
(b) — Phasp SP MP 19 Phast pBI121 
(c) — Phasp SP MP42 b p 8 o t m d b p s o c t Phast pRT1?1 
(d) _ Phasp SP MP 19 b p s o t m d b p s o c t Phast pRT19,1 
(e) — Phasp SP MP42 b p s o t m d a - T i P C T Phast pmi9,1 
(f) _ Phasp SP MP 19 b p s o t m d c x-tipct Phast pRT1?.1 
(g) — Phasp SP MP42 r m r t m d r m r c t Phast pRT19,l 
(h) Phasp SP MP42 r m r t m d r m r c t Phast pRT1?1 
Figure 4.3.1-1 Protein-targeting constructs 
a and b: controls ； c and d: a-TIP constructs; e and f: BP-80 constructs; and g and h: 
RMR constructs 
These constructs were checked for expected restriction fragments as shown in 
Figures 4.3.1-2 to -5. Hindlll was used to release the phaseolin cassette and Xba I, 
which cuts only one time in the vector backbone and in the phaseolin promoter, was 
used to check the orientation of the cassette. As the restriction sites at both ends of the 
protein targeting construct are the same, i.e. AccI sites, using PCR to check its 
orientation after cloning was done by using the 5' primer specific for MSPl42 or 
MSPl 19 and the 3' primer specific for the protein targeting sequence. Finally, DNA 
sequencing was performed to confirm the fidelity of the constructs (data not shown). 
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(a) ^ � ^ 
M 〜搶 • 
Hindi! Xbal Hindlll Xbal 
I pBI121 
Phasp SP MP42 Phast — 35S GUS NOS 
^ �3.51^^ ^ 
^ �2.7k ^ 
Hindi! Xbal Hindlll Xbal 
I pBI121 
Phasp SP MP 19 Phast — 35S GUS NOS 
1 2 3 4 5 6 7 8 9 lOM M 丄 2 3 4 5 6 
(b) (d) ^ ^ ^ ^ ^ ^ ^ ^ 
3.6kb m 
, , … - - . . - - .. . . , _•二 J — — ^ 
M 1 2 3 4 5 6 7 8 9 10 
— 800bp 
(c) i 
— • I . Under longer UV exposure time 
fe� ‘, ； jj^ iMsr^ ^^ * 丄 A^ LL^  ‘ if - ‘ r ||；| ‘ ly ;,| ！,‘:“』 
Figure 4.3.1-2 The Phas/SP/MP42 and Phas/SP/MP 19 constructs 
(a) Structure of the Phas/SP/MP42 and Phas/SP/MP 19 constructs in pBI121 
showing the position of the Hindlll abd Xbal sites and the fragment sizes; (b) 
Restriction digestion of the plasmid Phas/SP/MP42 by Hindlll and (c) by Xbal; (d) 
Restriction digestion of the plasmid Phas/SP/MP 19 by Xbal. Key: lane M: 1Kb plus 
DNA ladder (Invitrogen); lanes 1-10 and 1-6: the colony numbers; Arrow indicates 
the band position and size; and the underlined colony numbers denoted from 
Agrobacterium LBA4404 that used for transformation. 
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(a) ^ �4 . 6 k b ^ 
^ • 
^ �3.8kB ^ 
Hindll Xbal ^ �1 . 4 k b ^ Hindlll Xbal 
L PBI121 
Phasp SP MP42 bpsotmd bpsoct Phast — 35S GUS NOS 
^ �3 . 7 k b ^ 
M �2.9kB ^ 
Hindi! ^ �0.:5kb ^ Hindlll Xbal 
~ L PBI121 
Phasp SP MP19 BP80TMD bpso ct Phast 35S GUS NOS 
1 2 3 4 5 6 M M 1 2 3 4 5 6 7 8 
(b) (e) 
� 3 . 8 K b — • 
-2.9Kb 
1 2 3 4 5 6 M 1 2 3 4 5 6 7 8 M 
(C) 份 , 叹 T 縱 響 濟 , 释 ( f ) 释 二 ‘ f , 测 
�4 . 6 K b “ • ^ m 
� 3 .7 K b 
Under longer UV — 0 . 8 K b , , �i  
， Under longer UV exposure time 
exposure time 
, ‘ X - � i 丄 “ � �V v ^ « ‘ ‘ wvviv , - ‘ 
(d) (g) 
�l i b — • �0 . 4 K b — 4 l \ 
Figure 4.3.1-3 The Phas/SP/MP42-BP80 and Phas/SP/MP 19-BP80 constructs 
(a) Structure of the Phas/SP/MP42-BP80 and Phas/SP/MP 19-BP80 constructs 
showing the position of the Hindlll and Xbal sites, and the fragment sizes, (b) 
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restriction digestion of the plasmid Phas/SP/MP42-BP80 by Hindlll and (c) by Xbal; 
(d) PCR amplification of MP42- BPSO in the Phas/SP/MP42-BP80 construct using 
primers LNspM42 and RABP-80. (e) Restriction digestion of plasmid 
Phas/SP/MP19-BP80 by Hindlll and (f) by Xbal; (g) PCR amplification of 
MP19-BP80in the Phas/SP/MP19-BP80 using primers LNspM19 and RABP-80. Key: 
lane M: 1 Kb plus DNA ladder (Invitrogen); other lanes with numbers show the 
number of colonies; arrows show the band positions and sizes; the underlined colony 
indicated DNA from Agrobacterium LBA4404 that used for transformation. 
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^ �4.6kb ^ 
(a) ^ ~3.8kB ^ 
Hindlj ^ �1 . 3 k b ^ Hindlll Xbal 
L PBI121 
Phasp SP MP42 BPSOTMD OCTIPCT Phast 35S GUS NOS 
^ ~3.7kb ^ 
^ �2.9kB ^ 
Hindi! ^ �0 . 5 k b ^ Hindlll Xbal 
| _ pBI121 
Phasp SP MP19 BP80TMD axip CT Phast — 35S GUS NOS 
(b) 
Hindlll Xbal 
M 1 2 3 _ 4 _ 1 2 3 4 
Hindlll Xbal 
(C)  
1 _ 2 _ 3 4 1 丄 3 4 M 
m ^ ~3.7kb 
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Figure 4.3.1-4 The Phas/SP/MP42-a-TIP and Phas/SP/MP19-a-TIP constructs 
(a) Structure of the Phas/SP/MP42-a-TIP and Phas/SP/MP 19-a-TIP constructs 
showing the position of the Hindlll and Xbal sites and the fragment sizes; (b) 
restriction digestion of the plasmid Phas/SP/MP42-a-TIP by Hindlll or Xbal; (c) of 
Phas/SP/MP 19-a-TIP by Hindlll or Xbal. Key: lane M: 1 Kb plus DNA ladder 
(Invitrogen); lanes 1-4 show the colony numbers and the arrows show the position 
and size of DNA bands; and colonies underlined denoted those chosen for 
Agrohacterium LBA4404 transformation. 
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Figure 4.3.1-5 The Phas/SP/MP42-RMR and Phas/SP/MP19-RMR constructs 
(a) Structure of the Phas/SP/MP42-RMR and Phas/SP/MP 19-RMR constructs 
showing the position of Hindlll and Xbal sites and the fragment sizes; (b) restriction 
digestion of plasmid Phas/SP/MP42-RMR by Hindlll or (c) by Xbal (d) PCR 
amplification of the MP42-RMR in Phas/SP/MP42-RMR using primers LNspM42 
and RARMR; (e) restriction digestion of plasmid Phas/SP/MP 19-RMR by Hindlll 
and (f) by Xbal. Key: lane M: 1 Kb plus DNA ladder (Invitrogen); lane 1-4 and 1-6 
show the colony numbers; the arrows show the band positions and sizes; and the 
colonies underlined denoted those chosen for Agrobacterium LBA4404 
transformation. 
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(B) GUS fusion constructs 
Bl . Constructs for transient assay 
We hypothesized that GUS fusion may stabilize the expression of the MSPl 
transgene at protein level of the transgene in fusion with GUS showed positive 
expression in our earlier transient assay (section 4.1.2). Therefore, six chimeric GUS 
fusion gene constructs, namely pTZ/Phas/MP42: :EK-GUSN, 
pTZ/Phas/MP 19: :EK-GUSN, pBK/Phas/SP/MP42::EK-GUSN, 
pBKyPhas/SP/MP 19: :EK-GUSN, pBK/Phas/SP/MP42: :EK-GUSN-AFVY and 
pBK/Phas/SP/MP 19::EK-GUSN-AFVY were constructed (Figure 4.3.1-6) and tested 
for transient expression by particle bombardment before being transformed into 
tobacco via Agrohacterium (LB A 4404) 
The major restriction sites for the MSPl42 GUS fusion constructs are shown in 
Figure 4.3.1-7. AccI was used to release the M S P I 4 2 / G U S fragment from the 
pTZ/Phas/MP42: :EK-GUSN for verification whereas incomplete digestion by Ndel 
and PstI was used for checking the presence of the M S P I 4 2 gene and GUS gene in the 
constructs of pBK/Phas/SP/MP42: :EK-GUSN and 
pBK/Phas/SP/MP42: :EK-GUSN-AFVY. DNA sequencing was also performed to 
further confirmed the fidelity of the constructs (data not shown). 
In these chimeric gene constructs, the modified MSPI42 (MP42) and MSPl 19 
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(MP 19) cDNAs were fused with the GUS coding sequence without translation start 
codon (GUSN). The two coding sequences were linked by the enterokinase cleavage 
sequence (EK) for fusion separation of the two proteins. Some of the constructs 
(Figure 4.3.1-6 c-6) contained the phaseolin signal sequence (SP) while others also 
contained the Phaseolin vacuole targeting tetrapeptide (AFVY) signal (Figure 4.3.1-6 
e-f). All the fusion constructs were driven by the phaseolin promoter (Phasp) and 
terminator (Phast), in either pTZ or pBK vectors. 
(a) Phasp MP42 EK GUSN Phast pTZ 
(b) Phasp MP 19 EK GUSN Phast pTZ 
(c) Phasp SP MP42 EK GUSN Phast pBK 
(d) Phasp SP MP 19 EK GUSN Phast pBK 
(e) Phasp SP MP42 EK GUSN AFVY Phast pBK 
(f) Phasp SP MP 19 EK GUSN AFVY Phast pBK 
Figure 4.3.1-6 Modified MSPl and GUS fusion constructs for transient 
expression 
(a) pTZ/Phas/MP42: :EK-GUSN; (b) pTZ/Phas/MP 19: :EK-GUSN; (c) 
pBKyPhas/SP/MP42::EK-GUSN; (d) pBK/Phas/SP/MP 19::EK-GUSN; (e) 
pBK/Phas/SP/MP42::EK-GUSN-AFVY; and (f) 
pBK/Phas/SP/MP19::EK-GUSN-AFVY. Phasp=Phaseolin promoter; Phast= 
Phaseolin terminator; EK= enterokinase cleavage sequence; GUSN= GUS coding 
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Figure 4.3.1-7 Cloning of the MSPI42 and GUS fusion constructs 
(a) Diagram of the constructs pTZ/Phas/MP42: :EK-GUSN, 
pBK/Phas/SP/MP42: :EK-GUSN and pBK/Phas/SP/MP42: :EK-GUSN-AFVY; (b) 
restriction digestion of the plasmid pTZ/Phas/MP42::EK-GUSN by AccI; (c) 
restriction digestion of the plasmid pBK/Phas/SP/MP42: :EK-GUSN by Ndel and Pst; 
(d) restriction digestion of pBKyPhas/SP/MP42::EK-GUSN-AFVY by Ndel and PstI; 
arrows indicate the expected sizes of the bands on the gels. Key: lane M: 1 Kb plus 
DNA ladder (Invitrogen); lanes 1-4 and 1-6 represent colony numbers; colonies 
underlined denote those chosen for particle bombardment and further cloning. 
The major restriction sites for the MSPl 19 GUS fusion constructs are shown in 
Figure 4.3.1-8. AccI was used to release the MSPI19/GUS fragment from the 
pTZ/Phas/MP 19: :EK-GUSN whereas incomplete digestion by Ndel and PstI was used 
for checking the presence of the MSPl 19 and GUS genes in the constructs of 
pBK/Phas/SP/MP 19::EK-GUSN and pBKyPhas/SP/MP19::EK-GUSN-AFVY. In 
addition, DNA sequencing was performed to further confirmed the fidelity of the 
constructs (data not shown). 
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Figure 4.3.1-8 Cloning of the MSPI19 and GUS fusion constructs 
(a) Diagram of the constructs pTZ/Phas/MP 19: :EK-GUSN, 
pBK/Phas/SP/MP 19::EK-GUSN and pBK/Phas/SP/MP 19::EK-GUSN-AFVY; (b) 
restriction digestion of pTZ/Phas/MP 19: :EK-GUSN by AccI; (c) Restriction digestion 
of the plasmid pBK/Phas/SP/MP 19::EK-GUSN by Ndel and PstI;. (d) restriction 
digestion the plasmid pBK/Phas/SP/MP 19: :EK-GUSN-AFVY by Ndel and PstI; 
arrows indicate the expected sizes of the bands found on the gels. Key: lane M: 1 Kb 
plus DNA ladder (Invitrogen); lane 1-4 and 1-6 represent coloniy numbers;.colonies 
underlined denote those chosen for the particle bombardment and further cloning. 
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B2. Modification of GUS sequence 
Then enzymatic activity of GUS may be inactivated due to N-linked 
glycosylation of its one or two potential sites in the endoplasmic reticulum (ER) 
where oligosaccharide transferase is found in the lumenal side (Iturriaga et al., 1989). 
Yan et al. (1997) modified a potential glycosylation site of GUS by mutation 
(Asn-358 to Ser) and were able to prevent the inactivation of GUS activity. In the 
present study, as the phaseolin signal peptide was used in most of the GUS fusion 
constructs, it is possible that the signal sequence will direct the GUS fusion protein 
into ER where in the GUS activity could be inactivated. 
Therefore, mutation (Asn-358 to Ser) was introduced into the GUS gene 
constructs in which phaseolin signal peptide was present so as to test by transient 
assay if inactivation of GUS activity was due to N-linked glycosylation. MSPl 19 was 
used for the study because MSPl 19 gave much higher expression than MSPI42 in the 
transient assay. 
Two chimeric gene constructs with the modified GUS (MGUSN), 
pBK/Phas/SP/MP 19: :EK-MGUSN and pBK/Phas/SP/MP 19: :EK-MGUSN-AFVY, ‘ 
were constructed (Figure 4.3.1-9) and used for transient expression by particle 
bombardment. . 
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� — —P h a s p SP MP 19 EK MGUSN Phast pBK 
(b) Phasp SP MP 19 EK MGUSN AFVY Phast pBK 
Figure 4.3.1-9 Modified GUS-fusion constructs used for transient assay 
(a) pBK/Phas/SP/MP 19: :EK-MGUSN and (b) 
pBK/Phas/SP/MP 19::EK-MGUSN-AFVY. MGUSN二 modified (Asn-358 to Ser) 
GUS without translation start codon (ATG). 
The major restriction sites for the modified GUS (MGUS) fusion constructs 
are shown in Figure 4.3.1-10. Hindlll was used to release the phaseolin cassette from 
plasmid pBK/Phas/SP/MP 19::EK-MGUSN and 
pBK/Phas/SP/MP 19::EK-GUSN-AFVY for verification.. DNA sequencing was 
performed to further confirmed the mutation site of the GUS gene in the constructs 
(data not shown). 
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Figure 4.3.1-10 Cloning of the Phas/SP/MP19::MGUSN and 
Phas/SP/MP19::MGUSN-AFVY constructs 
(a) Diagram of the Phas/SP/MP19::MGUSN and Phas/SP/MP 19: :MGUSN-AFVY 
constructs showing the position of the Hindlll sites and the size of their franking 
fragments; (b) restriction digestion of the plasmid Phas/SP/MP 19::GUSN by Hindlll; 
and (c) of Phas/SP/MP 19::GUSN-AFVY. Key: lane M: 1 Kb plus DNA ladder 
(Invitrogen); lanes 1-5 show the colony numbers; arrows show the expected band 
positions and sizes; colonies underlined denote those chosen for the particle 
bombardment. 
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B3. Constructs for tobacco transformation 
For expression of the modified MSPl and GUS fusion proteins in tobacco, the 
three phaseolin promoter-directed MP42/GUSN and three MP19/GUS fusion 
constructs prepared for transient expression assay (Bl. of section 4.3.1) were excised 
from the pTZ and pBK vectors and inserted into the pSUNl vector, which is a 
modified pBI121 Agrobacterium binary vector in which the GUS marker gene is 
replaced by an orange fluorescent protein (OFP) gene as marker. 
The six chimeric gene constructs are pSUN 1 /Phas/MP42: :EK-GUSN, 
pSUN 1 /Phas/MP 19:: EK-GUSN, pSUN 1 /Phas/SP/MP42: :EK-GUSN, 
pSUN 1 /Phas/SP/MP 19: :EK-GUSN, pSUN 1 /Phas/SP/MP42: :EK-GUSN-AFVY and 
pSUN 1 /Phas/SP/MP 19::EK-GUSN-AFVY (Figure 4.3.1-11). They were introduced 
into Agrobacterium LBA4404 for tobacco transformation. 
(a) Phasp MP42 EK GUSN Phast pSUNl 
(b) Phasp MP 19 EK GUSN Phast pSUNl 
(c) Phasp SP MP42 EK GUSN Phast pSUNl 
(d) Phasp SP MP 19 EK GUSN Phast pSUNl 
(e) Phasp SP MP42 EK GUSN AFVY Phast pSUNl 
(f) Phasp SP MP 19 EK GUSN AFVY Phast pSUNl 
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Figure 4.3.1-11 Diagram of MSPl and GUS fusion constructs for tobacco 
transformation 
(a) pSUN 1 /Phas/MP42:: EK-GUSN; (b) pSUNl/Phas/MP 19: :EK-GUSN; (c) 
pSUNl/Phas/SP/MP42::EK-GUSN; (d) pSUNl/Phas/SP/MP19::EK-GUSN; (e) 
pSUNl/Phas/SP/MP42: :EK-GUSN-AFVY and (f) 
pSUNl/Phas/SP/MP19::EK-GUSN-AFVY. pSUNl is a modified pBI121 in which 
the GUS is preplaced by an orange fluorescent protein (OFP) as marker protein. 
The major restriction sites for the MSPl42 GUS fusion constructs in pSUNl 
are shown in Figure 4.3.1-12. To verify the constructs, Hindllll was used to release 
the phaseolin cassette from pSUN 1 /Phas/MP42: :EK-GUSN; Xbal was used to check 
the presence of the phaseolin cassette as well as its orientation in constructs 
pSUN 1 /Phas/SP/MP42: :EK-GUSN; and PCR with corresponding primers was used to 
amplified the M S P I 4 2 / G U S N and orange fluorescent protein (OFP) in 
pSUNl/Phas/SP/MP42::EK-GUSN-AFVY. DNA sequencing was performed to 
further confirm the fidelity of the constructs (data not shown). 
101 
Hindlll Hindlll  
~5.4kb  
(a) p  
Phasp MP42 EK GUSN Phast pSUNl 
^ �6 . 2 k b ‘ p. 
Xbal Xbal  
Phasp SP MP42 EK GUSN Phast — 35S pSUNl 
，1 u �0-6kb 
广 〜船 ^ ^ 
Phasp SP MP42 EK GUSN AFVY Phast 35S OFP NOS 
pSUNl 
M 1 2 3 4_ 5 6 
(b) 
< �5 . 4 k b 
扁 
1 2 3 5 6 M 
(c) 
^ �6 . 2 k b 
102 
( d ) MP42/GUS amplification OFP amplification 
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Figure 4.3.1-12 Cloning of the MSPI42 and GUS fusion constructs for tobacco 
transformation 
(a) Diagram of the plasmids pSUNl/Phas/MP42::EK-GUSN, 
pSUN 1 /Phas/SP/MP42: :EK-GUSN and pSUN 1 /Phas/SP/MP42: :EK-GUSN-AFVY; 
(b) restriction digestion of pSUNl/Phas/MP42::EK-GUSN by Hindlll;. (c) restriction 
digestion of pBKyPhas/SP/MP42: :EK-GUSN by Xbal; (d) PCR amplification of 
MP42/GUSN and OFP fragments in pBK/Phas/SP/MP42: :EK-GUSN-AFVY; arrows 
indicate the sizes of the bands. Key: M: 1 Kb plus DNA ladder (Invitrogen); lanes 1-6 
represent colony numbers; colonies underlined denote those chosen for introduction 
into Agrobacterium LBA 4404 for tobacco transformation. 
The major restriction sites of the MSPl 19 and GUS fusion constructs in 
pSUNl are shown in Figure 4.3.1-13. To verify the constructs, Hindlll was used to 
release the phaseolin cassette from pSUNl/Phas/MP 19::EK-GUSN; Xbal was used 
for checking the presence as well as the orientation of the phaseolin cassette in the 
constructs of pSUN 1 /Phas/SP/MP 19: :EK-GUSN; and PCR with corresponding 
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primers was used to amplify the M S P I 1 9 / G U S N and orange fluorescent protein (OFP) 
in the pSUNl/Phas/SP/MP 19: :EK-GUSN-AFVY. DNA sequencing was performed to 
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Figure 4.3.1-13 Cloning of the MSPI42 GUS fusion constructs for tobacco 
transformation 
(a) Diagram of the pSUN 1 /Phas/MP 19:: EK-GUSN, 
pSUN 1 /Phas/SP/MP 19::EK-GUSN and pSUNl/Phas/SP/MP19::EK-GUSN-AFVY; 
(b) restriction digestion of pSUNl/Phas/MP19::EK-GUSN by Hindlll.; (c) restriction 
digestion of pEK/Phas/SP/MP 19::EK-GUSN by Xbal; (d) PGR amplification of 
MP 19/GUSN and OFP in pBK/Phas/SP/MP 19: :EK-GUSN-AFVY The arrows 
indicate the sizes of the bands found on the gels�Key: lane M: 1 Kb plus DNA ladder 
(Invitrogen); lane 1-6 represent colony numbers; colonies underlined denoted those 
chosen for introduction into Agrobacterium LBA 4404 for tobacco transformation. 
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4.4 Transient assay of GUS fused MP42 and MP19 
constructs by particle Bombardment 
4.4.1 The GUS fusion constructs 
GUS flision may stabilize the expression of the modified MSPl gene at 
protein level as demonstrated by our earlier transient assay study (section 4.1.2). 
Constructs for transient assay were thus made (section 4.3. IB) and studied. 
In the study, the number of snow bean cotyledons showing blue dot 
development with different relative intensities was counted and the results were 
shown in Tables 4.4.1-1 a-b and in bar chart Figures 4.4.1-la-b. Photographs were 
also taken to illustrate the different levels of blue dot development by the six 
constructs (Figure 4.4.1-2 a-f and Figure 4.4.1-3 a-f). 
Constructs Phas/MP42::EK-GUSN and Phas/MP19::EK-GUSN were found to 
express and show blue dot development with different intensities, but not for the 
Phas/SP/MP42: :EK-GUSN, Phas/SP/MP 19: :EK-GUSN, 
Phas/SP/MP42::EK-GUSN-AFVY and Phas/SP/MP 19::EK-GUSN-AFVY, which 
showed no blue dot development. 
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Table 4.4.1-la: Transient expression of the modified MSPI42 constructs 
The particle bombarded-cotyledons showing one or more blue dots were regarded as 
positive results. Key: + indicates the relative intensity of blue dots (5+, maximum) 
Dish Positive Results Negative Total 
no. 5+ 4+ 3+ 2+ 1+ Results 
PTZ/Phas/GUSATG 1 1 1 1 2 7 1 13 
2 2 0 2_ 0 6 3 13 
PTZ/Phas/GUSN 1 ~Q 0 0 0 0 13 1 3 ^ 
2 0 0 0 _ 0 0 15 15 
PTZ/Phas/MP42::GUSN 1 1 1 2 3 7 14 
2 0 0 0 2 5 7 14 
PTZ/Phas/MP42-EK: :GUSN 1 0 0 0 " 1 1 n 14 
2 0 0 1 2 11 15 
PTZ/Phas/SP/MP42-EK: :GUSN 1 0 0 0 0 ~ 0 15 1 5 ^ 
2 0 0 0 _ 0 0 14 14 
PTZ/Phas/SP/MP42-EK:: GUSN-AFVY 1 0 0 0 0 0 15 15 
2 | o | o | o | o | o 15 15 
Table 4.4.1-lb: Transient expression of the modified MSPI19 constructs 
The particle bombarded-cotyledons showing one or more blue dots were regarded as 
positive results. Key: + indicates the relative intensity of blue dots (5+, maximum) 
Dish Positive Results Negative Total 
no. 5+ 4+ 3+ 2+ 1+ Results 
PTZ/Phas/GUSATG 1 1 0 1 1 6 5 15 
2 0 1 2 1 7 2 15 
PTZ/Phas/GUSN 1 0 0 ^ 0 0 15 15 
2 0 0 0 0 0 15 15 
PTZ/Phas/MP 19: :GUSN 1 0 0 1 0 _ 6 8 15 
2 0 1 2 2 3 7 15 
PTZ/Phas/MP 19-EK:: GUSN 1 0 2 2 3 5 3 15 
2 1 2 2 ^ 6 2 16 
PTZ/Phas/SP/MP 19-EK:: GUSN 1 0 0 0 0 0 15 15 
2 0 0 0 0 0 15 15 
PTZ/Phas/SP/MP 19-EK:: GUSN-AFVY 1 0 0 0 0 0 15 15 
2 I 0 I 0 I 0 0 0 15 15 
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Figure 4.4.1-la Transient expression of the MP42 constructs 
Constructs 1: pTZ/Phas/GUS; 2: pTZ/Phas/GUSN; 3: pTZ/Phas/MP42::GUSN; 4: 
pTZ/Phas/MP42-EK: :GUSN; 5: pBKyPhas/SP/MP42-EK::GUSN and 6: 
pBK/Phas/SP/MP42-EK::GUSN-AFVY. The relative intensities of blue dot in cotyledons 
are represented by different colours in the bar chart (5+=max. relative intensity). 
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Figure 4.4.1-lb Transient expression of the MP19 constructs 
Constructs 1: pTZ/Phas/GUS; 2: pTZ/Phas/GUSN; 3: pTZ/Phas/MP19::GUSN; 4: 
pTZ/Phas/MP19-E::GUSN; 5: pBK/Phas/SP/MP 19-EK: :GUSN and 6: 
pBK/Phas/SP/MP 19-EK:: GUSN-AFVY. The relative intensities of blue dot in cotyledons 
are represented by different colours in the bar chart (5+: max. relative intensity). 
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Figure 4.4.1-2 a-f Photographs illustrating the different levels of blue dot 
development in particle bombardment of MP42 and GUS fusion constructs 
Constructs (a) pTZ/Phas/GUSATG, positive control; (b) pTZ/Phas/GUSN, negative 
control; (c) Phas/MP42::GUSN; (d) Phas/MP42-EK::GUSN; (e) 
Phas/SP/MP42-EK::GUSN; and (f) Phas/SP/NP42-EK::GUSN-AFVY 
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Figure 4.4.1-3 a-f Photographs illustrating the different levels of blue dot 
development in particle bombardment of MP19 and GUS fusion constructs 
Constructs (a) pTZ/Phas/GUSATG, positive control; (b) pTZ/Phas/GUSN, negative 
control; (c) Phas/MP19::GUSN; (d) Phas/MP19-EK::GUSN; (e) 
Phas/SP/MP19-EK::GUSN; and (f) Phas/SP/NP19-EK::GUSN-AFVY 
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4.4.2 Modification of GUS sequence 
The two chimeric gene constructs with the modified GUS (Ans-358 to Ser, 
MGUSN), pBK/Phas/SP/MP 19: :EK-MGUSN and 
pBK/Phas/SP/MP 19:: EK-MGUSN-AF VY, as detailed in their construction in section 
4.3.1B2, and three controls, pTZ/Phas/MP 19::EK-GUSN (GUS without Asn-358 to 
Ser modification), pTZ/Phas/GUSN (GUS without ATG translation initiation codon as 
negative control)and pTZ/Phas/GUS (GUS with ATG codon as positive control) 
(Figure 4.4.2-1) were used in particle bombardment. The number of snow bean 
cotyledons showing blue dot development in different relative intensities was count. 
The results were shown in Tables 4.4.2-1 and as bar charts in Figure 4.4.2-2. 
Photographs were also taken to illustrate the different levels of blue dot development 
by the five constructs (Figure 4.4.2-3). 
Constructs Phas/GUS and Phas/MP 19::EK-GUSN were found to express and 
develop blue dots of different intensities, but not in Phas/GUSN, 
Phas/SP/MP 19: :EK-MGUSN, and Phas/SP/MP 19::EK-MGUSN-AFVY. 
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(a) Phasp GUS Phast pTZ 
(b) Phasp GUSN Phast pTZ 
(c) Phasp MP 19 EK GUSN Phast pTZ 
(d) Phasp SP MP 19 EK MGUSN Phast pBK 
(e ) Phasp SP MP 19 EK MGUSN AFVY Phast pBK 
Figure 4.4.2-1 Constructs with moditied GUS for transient expression assay 
Constructs (a) Phas/GUS (with ATG as a positive control); (b) Phas/GUSN (without 
ATG as a negative control); (c) Phas/MP19-EK::GUSN; (d) 
Phas/SP/MP 19-EK: :MGUSN; and (e) Phas/SP/MP 19-EK::MGUSN-AFVY. The 
GUS coding sequence without the translation initiation codon (GUSN) was sequence 
modified (Asn-358 to Ser) to give MGUSN. 
Table 4.4.2-1 Transient expression of the MP19 and modified GUS fusion 
constructs 
Particle bombarded cotyledon showing one or more blue dots were regarded as 
positive results. Key: + shows the relative intensity of blue dots (5+, maximum) 
Dish Positive Results Negative Total 
no. 5+ 4+ 3+ 2+ 1+ Results 
PTZ/Phas/GUS ATG 1 1 1 2 ^ 3 10 18 
2 3 _ _ 2 1_ 4 3 4 17 
PTZ/Phas/GUSN 1 0 _ _ _ 0 _ _ 0 _ _ 0 _ _ 0 19 19 
2 0 0 0 0 0 20 20 
PTZ/Phas/MP 19::GUSN 1 0 _ _ 0 _ _ 2 _ _ 1 _ _ 2 11 16 
2 1 1 1 1_ 4 8 16 
PTZ/Phas/SP/MP 19-EK: MGUSN 1 0 _ _ 0 _ _ 0 _ _ 0 _ _ 0 18 18 
2 0 0 0 0 0 17 17 
PTZ/Phas/SP/MP 19-EK: MGUSN-AFVY 1 0 _ _ 0 _ _ 0 _ _ 0 _ _ 0 17 17 
2 0 _ _ 0 _ _ ^ 0 0 16 16 
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Figure 4.4.2-2 Transient expression of the MP19 and modified GUS fusion 
constructs 
Constructs 1: pTZ/Phas/GUS; 2: pTZ/Phas/GUSN; 3: pTZ/Phas/MP19-EK::GUSN; 4: 
pBK/Phas/SP/MP19-EK::MGUSN; and 5: 
pBK/Phas/SP/MP19-EK::MGUSN-AFVY. The relative intensities of blue dot in 
cotyledons are represented by different colours in the bar chart (5+= max. relative 
intensity). 
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Figure 4.4.2-3 Photographs illustrating the transient expression of the modified 
GUS fusion constructs 
Snow bean cotyledons were bombarded with the following constructs (a) positive 
control: Phas/GUS; (b) negative control: Phas/GUSN; (c) Phas/MP 19-EK::GUSN; (d) 
Phas/SP/MP19-EK::MGUSN; and (e) Phas/SP/MP 19-EK: :MGUSN-AFVY. 
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4.5 Generation of transgenic tobacco 
(A) Protein targeting constructs 
First generation transgenic plants (Rl) were selected out on kanamycin 
shooting medium after tobacco transformation of the protein targeting chimeric 
constructs Phas/SP/MP42, Phas/SP/MP42-BP80, Phas/SP/MP42-aTIP, 
Phas/SP/MP42-RMR, Phas/SP/MP 19, Phas/MP19-BP80 and Phas/MP19-RMR 
(Figure 4.3.1-1). The selected transgenic plants were then transferred to rooting 
medium and the leaves of the plants were collected for GUS staining (Figure 4.5-1 
and.4.5-2). 
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_ J 3 5 12 WT 
i # # i 
Phas/SP/MP42-BP80 Phas/SP/MP42-aTIP Phas/SP/MP42-RMR 
1 7 8 1 2 5 
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Figure 4.5-1 Integration of chimeric gene constructs into tobacco plant genome-
GUS staining of tobacco plants transformed with the NP42 protein targeting 
constructs 
Leaves from tobacco plants transformed with Phas/SP/MP42, Phas/SP/MP42-BP80, 
Phas/SP/MP42-a-TrP, or Phas/SP/MP42-RMR and wild type plants (WT, Control) 
were GUS stained. Numbers indicate the line numbers of transgenic plants harboring 
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the respective gene constructs. 
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Figure 4.5-2 Integration of chimeric gene constructs into tobacco plant genome 
-GUS staining of tobacco plants transformed with the MP19 protein constructs 
Leaves from tobacco plants transformed with Phas/SP/MP 19, Phas/SP/MP 19-BP80, 
or Phas/SP/MP 19-RMR and wild type plants (WT, control) were GUS stained. 
Numbers indicate the line numbers of transgenic plants harboring respective gene 
constructs. 
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(B) GUS fusion constructs 
First generation transgenic plants (Rl) were selected out on kanamycin 
shooting medium after tobacco transformation for each of the chimeric constructs 
PSUN1 /Phas/MP42:: EK-GUSN, pSUNl /Phas/MP 19: :EK-GUSN, 
pSUNl/Phas/SP/MP42::EK-GUSN, pSUN 1 /Phas/SP/MP 19:: EK-GUSN, 
pSUNl/Phas/SP/MP42::EK-GUSN-AFVY, 
pSUNl/Phas/SP/MP19::EK-GUSN-AFVY (Figure 4.3.1-11). The selected transgenic 
plants were then transferred to rooting medium and the leaves of the plants were 




Transgenic Wild type 
Figure 4.5-3 Microscopic view of transgenic and wild type tobacco 
Leaves from tobacco plants transformed with MP42 and MP 19 GUS fusion constructs 
were collected and viewed under fluorescent microscope using orange fluorescent 
filter, (a) under light field (b) under orange fluorescent filter 
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4.6 Southern analysis 
The integration of MP42 and MP 19 in the plant genome was confirmed by 
Southern blot analysis. Genomic DNA of the lines was extracted and digested with 
BamHI which cuts only one time in the T-DNA backbone, but not in the transgene. 
MP42 or MP 19 specific probe was used to detect the transgene sequence. The copy 
number of the transgene integration were estimated through the hybridization results. 
From this analysis, transgenic plants were selected from each constructs for further 
analysis. A total of 35 transgenic lines were selected (Table 4.6-1). 
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Figure 4.6-1 Southern analysis of MP42 transgenic tobacco 
Genomic DNA (15|dg) was digested with BamHI, was separated by gel electrophoresis and 
blotted onto a nylon membrane for hybridization and detection. The lines (boxed) were used for 
further Northern and Western analysis. 
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Figure 4.6-2 Southern analysis of MP19 transgenic tobacco 
Genomic DNA (15ug) was digested with BamHI, was separated by gel 
electrophoresis and blotted onto a nylon membrane for hybridization and detection. 
The lines (boxed) were used for further northern and Western analysis. 
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Table 4.6-1: Transgenic lines selected from constructs for further analysis 
Protein-targeting constructs GUS fusion constructs 
MSPI42 MSPl 19 MSPI42 MSPl 19 
Phas/SP/MP42 Phas/SP/MP19 Phas/MP42-EK::GUSN Phas/MP 19-EK: :GUSN 
Lines 1, 3, 5, 12 Lines 4, 8, 11, 13 Lines 4, 6, 15 Line 8 
Phas/SP/MP42-BP80 Phas/SP/MP 19-BP80 Phas/SP/MP42-EK: :GUSN Phas/SP/MP 19-EK: :GUSN 
Line 1 Lines 3, 5, 13, 15, 25 Line 7 Lines 2, 6, 7, 11, 12 
Phas/SP/MP42-a-TIP Phas/SP/MP42-EK: :GUSN Phas/SP/MP 19-EK:: GUSN 
Lines 7, 8 -AFVY -AFVY 
Line 15 Lines 2, 5, 7, 11’ 16 
Phas/SP/MP42-RMR Phas/SP/MP 19-RMR 
Lines 1, 2, 5 Line 2 
124 
4.7 Northern analysis 
(A) Protein-targeting constructs 
The transgene expression of the protein-targeting constructs Phas/SP/MP42, 
Phas/SP/MP42-BP80, Phas/SP/MP42-a-TIP, Phas/SP/MP42-RMR, Phas/SP/MP 19, 
Phas/SP/MP 19-BP80, and Phas/SP/MP 19-RMR, at transcriptional level was studied 
by northern blotting analysis using developing tobacco seed RNA and MP42 or MP 19 
specific probe (Figures 4,7-1, 4.7-2, 4.7-3 and 4.7-4). Transcripts of expected size 
were detected in all the constructs under study. 
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Figure 4.7-1 Northern analysis of transgenic Phas/SP/MP42 and Phas/SP/MP19 
tobacco plants 
Total developing tobacco seed RNA (8 |ig) was resolved in 1% RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
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detection with MP42 or MP 19 specific probe, (a) construct Phas/SP/MP42 and (b) 
construct Phas/SP/MP 19. Key: WT: wild type; numbers represent the line numbers of 
each of the construct; M l : 0.16-1.77kb RNA ladder (Invitrogen); M2: 0.24-9.5Kb 
RNA ladder (Invitrogen); arrows show the expected sizes of the transcripts. 
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Figure 4.7-2 Northern analysis of transgenic tobacco with BPSO constructs 
Total developing tobacco seed RNA (8 |Lig) was resolved in 1 % RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
detection with MP42 or MP 19 specific probe, (a) Construct Phas/SP/MP42-BP80 and 
(b) construct Phas/SP/MP 19-BP80. Key: WT: wild type; numbers represent the line 
numbers of each construct; Ml : 0.16-1.77Kb RNA ladder (Invitrogen); M2: 
0.24-9.5kb RNA ladder (Invitrogen); arrows show the expected sizes of the 
transcripts. 
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Figure 4.7-3 Northern analysis of transgenic tobacco of a-TIP constructs 
Total developing tobacco seed RNA (8|Lig) was resolved in 1% RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
detection with MP42 specific probe. Key: WT: wild type; numbers represent the line 
numbers of the Phas/SP/MP42-aTIP construct; Ml : 0.16-1.77Kb RNA ladder 
(Invitrogen); M2: 0.24-9.5kb RNA ladder (Invitrogen); arrows show the expected size 
of the transcript. 
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Figure 4.7-4 Northern analysis of transgenic tobacco with RMR constructs Total 
developing tobacco seed RNA (8|Lig) was resolved in 1% RNA denaturating gel and 
the resolved RNA was blotted onto a nylon membrane for hybridization and detection 
with MP42 or MP 19 specific probe, (a) Construct Phas/SP/MP42-RMR and (b) 
Construct Phas/SP/MP 19-RMR. Key: WT: wild type; numbers represent the line 
numbers of each construct; Ml: 0.16-1.77Kb RNA ladder (Invitrogen); M2: 
0.24-9.5kb RNA ladder (Invitrogen); arrows show the expected sizes of the 
t r a n s c r i p t s . 
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(B) GUS fusion constructs 
Northern blotting analysis using total developing seed RNA and MP42 or MP 19 
specific probe was carried out to study the transgene expression of constructs 
Phas/MP42: :EKGUSN, Phas/SP/MP42::EK-GUSN, Phas/MP 19: :EK-GUSN, 
Phas/SP/MP 19: :EK-GUSN, and Phas/SP/MP 19: :EK-GUSN-AFVY at mRNA level 
(Figure 4.7-5 and 4.7-6). Transcripts with expected size were detected. 
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Figure 4.7-5 Northern analysis of transgenic Phas/MP42::EK-GUSN and 
Phas/MP19::EK-GUSN tobacco plants 
Total developing tobacco seed RNA (8|ig) was resolved in 1% RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
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detection with MP42 or MP 19 specific probe, (a) construct Phas/MP42::EK-GUSN 
and (b) construct Phas/MP 19::EK-GUSN. Key: WT: wild type; numbers represent the 
line numbers of each of the construct; M l : 0.16-1.77Kb RNA ladder (Invitrogen); M2: 
0.24-9.5Kb RNA ladder (Invitrogen); arrows show the expected sizes of the 
transcripts. 
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Figure 4.7-6 Northern analysis of transgenic Phas/SP/MP42::EK-GUSN and 
Phas/SP/MP19::EK-GUSN tobacco plants 
Total developing tobacco seed RNA (8|Lig) was resolved in 1% RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
detection with MP42 or MP 19 specific probe. (a) Construct 
Phas/SP/MP42::EK-GUSN and (b) Construct Phas/SP/MP 19::EK-GUSN. Key: WT: 
wild type; numbers represent the line numbers of each construct; Ml : 0.16-1.77kb 
RNA ladder (Invitrogen); M2: 0.24-9.5kb RNA ladder (Invitrogen); arrows show the 
expected sizes of the transcripts. 
130 
(a) Ml M2 15 WT 
國 ： 
i ^ •�3Kb 
J 
(b) Ml M2 5 7 11 16 WT 
_ . 
• ^ - 一 
• 
L � 
Figure 4.7-7 Northern analysis of transgenic Phas/SP/MP42::EK-GUSN-AFVY 
and Phas/SP/MP19::EK-GUSN-AFVY tobacco plants 
Total developing tobacco seed RNA (Sjug) was resolved in 1% RNA denaturating gel 
and the resolved RNA was blotted onto a nylon membrane for hybridization and 
detection with MP 19 specific probe, (a) construct Phas/SP/MP42: :EK-GUSN-AFVY 
and (b) construct Phas/SP/MP 19: :EK-GUSN-AFVY. Key: WT: wild type; numbers 
represent the line numbers of each construct; Ml : 0.16-1.77Kb RNA ladder 
(In vitro gen); M2: 0.24-9.5Kb RNA ladder (Invitrogen); arrows show the expected 
sizes of the transcripts. 
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4.8 Western analysis 
(A) Protein-targeting constructs 
Western blotting analysis was used to detect the expression of recombinant 
target protein in transgenic tobacco seeds. All of the lines used for western analysis 
had been shown to give positive results in the northern analysis (Figures 4.7-1, 4.7-2, 
4.7-3 and 4.7-4). 
Fifty |Lig of seed total protein from different lines of each construct was used 
for the western blot and varying amounts of purified His-MP42 were also included, so 
as to estimate the recombinant protein production. 
As shown in Figure 4.8-1, the highest expression of the recombinant target 
protein was found for construct Phas/SP/MP42-a-TIP, amounting to 0.4% of the total 
seed protein. For the BPSO constructs, the expression of the recombinant protein was 
estimated as 0.04% and 0.06% in the Phas/SP/MP42-BP80 and Phas/SP/MP 19-BP80 
transgenic seeds, as 53KD and 19KD proteins, respectively. About 0.1% recombinant 
protein with expected size (43KD) was found for construct Phas/SP/MP42 containing 
only the phaseolin signal peptide, while multiple protein bands with different 
intensities were detected for the Phas/SP/MP 19 construct. 
No recombinant protein was detected in the RMR constructs. 
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Figure 4.8-1 Western analysisof tobacco plants transformed with 
protein-targeting constructs 
(a) The calculated MW of proteins; (b-2 to g-2) total seed proteins (50^g) was 
resolved in 16.5% tricine gel with (3-mercaptoethanol and the sample was boiled 
before loading for the MP42 constructs but not for MP 19 constructs, blotted onto 
PVDF membrane, and was detected using anti-MSPUi serum as primary antibody 
and alkaline phosphatase conjugated anti-rabbit IgG as secondary antibody; (b-1 to 
g-1) Coomassie blue stained. The numbers represent line numbers of each construct. 
Purified protein His-MSPUi, as 47.8KD protein, was included as a positive control 
with concentration as indicated; (b) SP/MP42; (c) SP/MP19; (d) SP/MP42-BP80; (e) 
SP/MP19-BP80; (f) SP/MP42-aTIP; and (g) SP/MP42-RMR and SP/MPl9-RMR. 
Key: WT, wild type; M l , Bench Mark Protein Ladder (In vitro gen); M2, Precision 
Plus Protein Dual Standards (Bio-Rad). Arrows indicate major proteins reacted with 
the MSPl antibody. 
137 
(B) GUS fusion constructs 
For the GUS fusion constructs, altogether six constructs, 
Phas/MP42-EK::GUSN, Phas/MP 19-EK: :GUSN, Phas/SP/MP42-EK: :GUSN, 
Phas/SP/MP 19-EK:: GUSN, Phas/SP/MP42-EK:: GUSN-AFVY and 
Phas/SP/MP 19-EK::GUSN-AFVY, were studied. All lines used in the analysis had 
been shown to give positive mRNA signals in northern analysis (Figures 4.7-5, 4.7-6 
and 4.7-7). 
Results revealed that recombinant target proteins were detected in the 
constructs with phaseolin signal peptide. Around 0.04% and more than 0.02% of the 
total seed protein of transgenic Phas/SP/MP42-EK: :GUSN and 
Phas/SP/MP 19-EK::GUSN tobacco seeds were 109KD protein and 77KD protein, 
respectively. The expression of Phas/SP/MP42-EK:: GUSN-AFVY and 
Phas/SP/MP 19-EK:: GUSN-AFVY, with proteins of 109KD and 77KD, respectively, 
was estimated to yield around 0.16% and more than 0.04% as total seed protein, 
respectively. 
No recombinant protein was detected in the constructs without the phaseolin 
signal peptide, i.e. Phas/MP42-EK::GUSN and Phas/MP 19-EK::GUSN. 
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, � 1Q9KD  
(a) ^ m z z i i z z i j z i i i f i i i z i z i i z i ^  
Phasp MP42 EK GUSN Phast pSUNl 
77KD  
Phasp MP19 EK GUSN Phast pSUNl 
109KD  
Phasp SP MP42 EK GUSN Phast pSUNl 
77KD  
Phasp SP MP 19 EK GUSN Phast pSUNl 
IIQKD  
Phasp SP MP42 EK GUSN AFVY Phast pSUNl 
78KD  
Phasp SP MP 19 EK GUSN AFVY Phast pSUNl 
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Figure 4.8-2 Western analysis of transgenic tobacco with GUS fusion constructs 
(a) The calculated MW of the intact recombinant proteins; (b-2 to f-2) Total seed 
protein (50/ig) was resolved in 16.5% tricine gel with P-mercaptoethanol with the 
sample boiled for MP42 construct but not the MP 19 constructs, blotted onto PVDF 
membrane, and detected using anti-MSPl42 serum as primary antibody and alkaline 
phosphatase conjugated anti-rabbit IgG as secondary antibody and (b-1 to f-1) 
Coomassie blue stained. The numbers represent the line numbers of each construct. 
Purified protein His-MSPl42 was included as a positive control with concentration as 
indicated; (b) SP/MP42::EKGUSN and SP/MP19::EK-GUSN; (c) 
SP/MP42::EK-GUSN; (d) SP/MP19::EK-GUSN; (e) SP/MP42::EK-GUSN-AFVY; 
and (f) SP/MP19::EK-GUSN-AFVY. Key: WT, wild type; Ml , Bench Mark Protein 
Ladder (Invitorgen); and M2, Precision Plus Protein Dual Standards (Bio-Rad). 
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4.9 Detection of MP42 and MP19 in soluble and insoluble 
fraction of transgenic tobacco seeds 
To find out the localization of the recombinant target protein in the transgenic 
cells, the lines giving the highest recombinant protein expression of each construct, 
Phas/SP/MP42 (line 12)，Phas/SP/MP42-aTIP (line 8)，Phas/SP/MP42-BP80 (line 1)， 
were used for this studied (Figure 4.8-1 and 4.8-2). 
The recombinant proteins were mainly detected in the cell membrane (CM) 
fraction of the MSPl42 constructs and the constructs with a-TIP (Figure 4.9-1(2); 
Figure 4.9-2(1)) and AFVY (Figure 4.9-2(3) gave relatively high expression. However, 
cell soluble (CS) fraction of MSPl 19 constructs contains more recombinant protein 
than the CM fraction (Figure 4.3-3). 
(1) (2) (3) 
Purified SP/MP42 SP/MP42-aTIP Sp/MP42-BP80 WT 
His-MP42 M CS CM CS CM CS _CM CS CM 
r f � lOOKD 
�5 3 K D — ‘ ——50KD 
�4 3 K D • 
Figure 4.9-1 Detection of MP42 in soluble and insoluble fractions, with or 
without targeting sequence, in transgenic tobacco seeds 
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Constructs (1) Phas/ SP/MP42 (line 12); (2) Phas/SP/MP42-aTIP (line 8); and (3) 
Phas/SP/MP42-BP80 (line 1) were studied and as indicated in gel lanes, 1, 2 and 3, 
respectively. Soluble seed proteins (50/ig)’ as CS fraction, and insoluble seed proteins 
(50/xg), as CM fraction, were resolved in 16.5% tricine gel with P-mercaptoethanol, 
after boiling in dissociating buffer, blotted onto PVDF membrane, and detected using 
anti-MSPl42 serum as primary antibody and alkaline phosphatase conjugated 
anti-rabbit IgG as secondary antibody. Purified protein His-MSPl42 (50jitg) was 
included as a positive control. Key: WT, wild type and M, Precision Plus Protein Dual 
Standards (Bio-Rad). 
(1) (2) (3) 
SP/MP42-aTIP SP/MP42- SP/MP42- WT 
Purified EK::GUSN EK::GUSN-AFVY  
His-MP42 M CS CM CS CM CS CM CS CM 
~109KD ^ _ l O O K D 
�5 3 K D ^ _ 5 0 K D 
�4 3 K D • 
Figure 4.9-2 Detection of MP42 in soluble and insoluble fractions, with targeting 
sequences and/or GUS fusion, in transgenic tobacco seeds 
Constructs (1) Phas/ SP/MP42-aTIP (line 8 ) ; � Phas/SP/MP42-EK::GUSN (line 7); 
and (3) Phas/SP/MP42-EK::GUSN-AFVY (line 15) were studied and as indicated in 
gel lanes 1, 2 and 3, respectively. Soluble seed proteins (50jUg), as CS fraction, and 
insoluble seed proteins (50/xg), as CM fraction, were resolved in 16.5% tricine gel 
with P-mercaptoethanol. After boiling in dissociation buffer, blotted onto PVDF 
membrane, and was detected using anti-MSPUa serum as primary antibody and 
alkaline phosphatase conjugated anti-rabbit IgG as secondary antibody. Purified 
protein His-MSPUz (0.03/xg) was included as a positive control. Key: WT, wild type 
and M, Precision Plus Protein Dual Standards (Bio-Rad). 
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(1) � (3) 
SP/MP19 SP/MP19-BP80 SP/MP19-EK WT 
Purified ::GUSN  
His-MP42 M CS CM CS CM CS CM CS CM 
50KD 
20KD 
Figure 4.9-3 Detection of MP19 in soluble and insoluble fractions, with or 
without targeting sequence or GUS fusion in transgenic tobacco seeds 
Constructs (1) Phas/ SP/MP19 (line 8); (2) Phas/SP/MP 19-BP80 (line 25); and (3) 
Phas/SP/MP 19-EK::GUSN (line 2) were studied and as indicated in gel lane 1, 2 and 
3, repectively. Soluble seed proteins (SO/ig), run as CS fraction, and insoluble seed 
proteins (SOjitg), run as CM fraction, were resolved in 16.5% tricine gel with 
3-mercaptoethanol, after boiling with dissociation buffer, blotted onto PVDF 
membrane, and detected using anti-MSPl42 serum as primary antibody and alkaline 
phosphatase conjugated anti-rabbit IgG as secondary antibody. Purified protein 
His-MSPl42 (0.03jLtg) was included as a positive control. Key: WT, wild type and M, 
Precision Plus Protein Dual Standards (Bio-Rad). 
145 
Chapter 5 Discussion 
In this study, the significant findings are, firstly, the transcript of the 
previously non-transcribable native MSPl42 cDNA can be detected after sequence 
optimization of the cDNA for plant expression. Secondly, by fusing the trans gene 
with sequence for protein targeting or P-glucuronidase (GUS), production of 
recombinant MSPl42 and MSPl 19proteins were improved. 
In a previous study performed by our group, the expressions of MSPl42 in 
tobacco and Arabidopsis were not satisfactory because only trace amount or no 
mRNA was detected in the transgenic plants and no recombinant protein was detected 
by western analysis. We reasoned that the native MSPl42 cDNA may be not stable or 
suitable for plant expression. The MSPl42 cDNA was thus plant-optimized (Ng, 
2001). 
Before transformation of the optimized MSPl42 cDNA into plants, transgene 
expression of the modified cDNA was studied by transient assay using particle 
bombardment (Results 4.1). In the transient assay, both modified and unmodified 
MSPl42 and MSPl 19 cDNA were fused separately with a GUS reporter gene. In the 
fusion, the start codon (ATG) of GUS was removed, so that GUS expression (blue dot 
development) totally depends on the read through of the MSPl42 and MSPI19CDNA 
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during translation. Besides, to prevent technical errors in comparing the relative 
intensities of blue-dot development, such as variation of incubation conditions and 
qualities of different batches of beans bought in different times, the relative intensities 
were compared among the cotyledons in each individual tests. 
In the transient expression study, firstly, GUS expression was found for the 
modified MSPl42 and MSPl 19 cDNA constructs, i.e. Phas/MP42 and Phas/MP19, 
suggesting that elimination from the native MSPl42 cDNA the AT-rich nucleotides, the 
ATTTA pentamer, the AATAAA/AATAAA like-motifs, and the A+T nucleotide in the 
third degenerate base that are not favourable in plant system, enhances the stability of 
transcripts. 
Secondly, the shorter MSPl cDNA, namely MSPl 19’ showed better gene 
expression than the longer MSPl42, as greater number of cotyledons bombarded with 
the modified MSPl 19 cDNA gave blue dot development than the unmodified one. 
Therefore, the transient assay demonstrated that the optimized MSPl42cDNA 
allows the expression of MSPl protein in plant systems and the MSPl 19 cDNA will 
give a greater recombinant protein expression in transgenic plants. 
Based on the transient assay, the modified MSPI42 and MSPl 19 cDNA were 
transformed into Arabidopsis (Results 4.2). The expression of MSPI42 and MSPl 19 
transgenes was greatly improved as transcripts were detected by northern analysis 
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(Results 4.2.4). However, no recombinant protein could be detected by western 
analysis (Results 4.2.5). This is inconstant with the positive results from transient 
assay (Results 4.1). 
It is possible that for some unknown reason that the MSPI42 and MSPl 19 
mRNAs were not translated in the plant system. However, it is more likely that 
proteins produced are unstable for accumulation, either digested by proteases or 
because the MSPl42 and MSPl 19 proteins, which contain a large number of cysteine 
residues and disulphide bridges, may not be stable in the reducing environment of the 
cytosol. It has been reported that the expression of secretary proteins containing a 
large number of cysteine residues and disulphide bridges in cytoplasm was very low 
(Bosch et al., 1994; Florack et al., 1994). GUS is a stable protein and in fusion it may 
stabilize the MSPl42 and MSPl 19 expression, as blue-dot development could be 
detected in the transient assay but not in the transgenic Arabidopsis when no GUS 
fusion was included in the constructs. 
Therefore, sequence modification alone may not be sufficient for stable 
accumulation of recombinant MSPl42 and MSPl 19 proteins in transgenic plants. 
Further optimization are required. 
We hypothesize that by incorporating protein targeting sequences (Literature 
review, 2.13) or fusing GUS gene with the proteins, the expressed MSPI42 and 
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MSPl 19 recombinant proteins may be stabilized and enhanced. The protein targeting 
sequences, a-TIP and BP-80, suggested to direct foreign proteins to the membrane of 
the protein storage vacuole of the tobacco seeds (Jiang and Rogers, 1998 and 1999) 
were used in this study; whereas RMR, which is isolated from Arabidopsis , may 
target the foreign proteins to the membrane of the protein storage vacuole. 
In addition, GUS fusion may stabilize the MSPl42 and MSPl 19 expression, it 
was included in making fusion constructs. Several considerations were made on 
incorporating the GUS gene with MSPl. Firstly, as GUS may interfer the anti-malaria 
function, so an enterokinase (EK) site was inserted between the MSPl gene and the 
GUS gene for later removal of the GUS from the MSPl proteins. Secondly, as the 
expression of MSPl42 showed a marked improvement by adding the phaseolin 
targeting signal, AFVY (Lau, 2003), so this signal was also incorporated in one of the 
GUS fusion constructs. Thirdly, GUS at the same time can serve as a reporter gene in 
transient assay. When the GUS fusion constructs were tested for expression by 
particle bombardment before plant transformation, the expression of the MSPl42 and 
MSPl 19 through fusion with GUS was observed in a short time. 
By transient expression assay of the GUS fusion with MSPl42 and MSPl 19 
(Results 4.4.1), protein expression, as evident by blue-dot development, could be 
detected for constructs Phas/MP42-EK::GUSN and Phas/MP 19-EK::GUSN, but not 
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for Phas/SP/MP42-EK:: GUSN, Phas/SP/MP 19-EK:: GUSN, 
Phas/SP/MP42-EK:: GUSN-AFVY and Phas/SP/MP 19-EK:: GUSN-AFVY. The 
unexpressed GUS gene should not be due to any mutation in the sequences of MSPI42 
cDNA, MSPl 19 cDNA, the phaseolin signal peptide, the phaseolin targeting signal 
(AFVY) and the EK site, as DNA sequencing was performed in the cloning steps to 
ensure the sequences were correct. These DNA fragments were cloned in frame, so 
the unexpression should not be because of frame shift. Furthermore, the GUS cDNA 
used in the cloning of Phas/MP42-EK::GUSN, Phas/MP 19-EK:: GUSN, 
Phas/SP/MP42-EK: :GUSN and Phas/SP/MP 19-EK::GUSN were excised from the 
same clone, Phas/MP42::GUSN, and the GUS gene could be expressed in the former 
two constructs but not the latter two in the transient assay (Results 4.4.1), so the 
unexpressed GUS in constructs Phas/SP/MP42-EK: :GUSN and 
Phas/SP/MP 19-EK:: GUSN should not be because of the fidelity of the GUS gene. 
By grouping the constructs into two categories, namely GUS expressed or not 
expressed, the unexpressed GUS constructs Phas/SP/MP42-EK: :GUSN, 
Phas/SP/MP 19-EK:: GUSN, Phas/SP/MP42-EK:: GUSN-AFVY and 
Phas/SP/MP 19-EK:: GUSN-AFVY share a common sequence of phaseolin signal 
peptide, which was not present in the constructs that allowed GUS expression. It thus 
suggests that the phaseolin signal peptide may be the cause of failed expression. The 
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presence of signal peptide had been shown to translocate GUS to the endoplasmic 
reticulum (ER) where the GUS was modified by glycosylation and lost its enzymatic 
activity (Iturriaga et al., 1989). There are two potential sites in GUS for glycosylation, 
at position 358 to 360 and 423 to 425. By using the modified GUS reporter gene, in 
which one of the two potential glycosylation sites was mutated (Asn-358 to Ser), the 
inactivation of GUS enzymatic activity was prevented (Yan et al., 1997). Therefore, 
mutation of the GUS gene by changing Asn-358 to Ser was done in my study and 
transient assay of the constructs with mutated GUS (MGUSN) was performed 
(Results 4.4.2). 
After mutating the GUS genes in the MSPI42 and MSPl 19 constructs 
containing phaseolin signal peptide, however, transient assay still showed no GUS 
expression as no blue dot was observed (Results 4.4.2). This may be due to several 
reasons. First, the MSPI42 and MSPI19CDNA for some reason could not be expressed 
at translational level in the presence of phaseolin signal peptide. As the start codon of 
the GUS gene was removed, so GUS could not be expressed. Second, only one of the 
two potential glycosylation sites in the GUS gene was mutated, and this may not be 
sufficient to prevent enzymatic inactivation. Third, the recombinant protein of 
MSPI42 and MSPl 19 in fusion with GUS may fold in a form which inactivates the 
enzymatic activity of GUS; therefore, GUS may be translated, but lost its enzymatic 
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activity. This can be studied by using anti-(3-glucuronidase antibody in the western 
analysis of the transgenic tobacco seeds. 
For transgenic expression of the protein targeting and GUS fusion constructs 
in transgenic tobacco seeds, by northern analysis, transcripts were detected in all 
protein-targeting and GUS fusion constructs (Results 4.7), demonstrating that the 
transgene expression of MSPI42 and MSPl 19 can be greatly improved at 
transcriptional level after the codon usage was made more plant based. 
Expression of the MSPI42 and MSPl 19 proteins was detected by western 
analysis and their expression levels were found to vary according to different 
protein-targeting sequences or GUS fusion. Among all of the constructs, MSPl42 with 
a-TIP showed the highest protein expression, amounting to 0.4% of the total seed 
protein. The second highest protein expression was MSPl42 fusion with GUS and 
AFVY, around 0.16% of total seed protein. MSPl42 with phaseolin signal peptide 
resulted in 0.1% expression level, while the rest of the constructs, ranged from 0.02% 
to 0.04% of the total seed protein. The RMR constructs did not give any expression at 
the protein level (Results 4.8). The protein expression level at 0.4% of total seed 
protein was 2-fold higher than the 0.2% expression levels obtained for rhG-CSF in 
tobacco seed (Lee, 2002) 
The seed proteins extracted from MSPl42transgenic seeds were in denatured 
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forms for the western analysis because the anti-MSPUi rabbit serum used as primary 
antibody can recognize both linear and conformational epitopes on the MSPl42 
protein. After denaturation, the MSPl42 recombinant protein could be separated and 
linearized. Therefore, the expressed recombinant protein could be observed as a sharp 
band in comparing with the purified M S P I 4 2 protein in western analysis. However, 
the proteins extracted from the MSPl 19transgenic seeds should not be denatured by 
treatment with boiling and P-mercaptoethanol, because the anti-MSPUi rabbit serum 
could only recognize the conformational epitope on the C-terminal of MSPl42, that is 
the MSPl 19 fragment. As a result, a complex protein pattern, possibly due to the 
formation of dimmers, trimmers and higher mass of MSPl 19 mainly around 40KD and 
60KD, were observed in the western blotting of the MSPl 19 transgenic seeds. 
Therefore, the expression of the fusion constructs of MSPl 19 should amount to more 
than 0.02% and 0.04%, as only the intensity of the major bands was used in the 
quantitation (Results 4.8). 
The recombinant proteins produced by the constructs MSPl42 with a-TIP and 
with BP-80 were round 52 KD, indicating that the protein-targeting sequences were 
not cleaved off during protein synthesis and targeting. Proteins at around 11OKD were 
detected in the M S P I 4 2 / G U S fusion constructs Phas/SP/MP42-EK: :GUSN and 
Phas/SP/MP42-EK::GUSN-AFVY, suggesting that the recombinant protein consists 
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of MSP142 and GUS. For the AFVY construct, a major protein band at around 42KD 
was detected in the western analysis, suggesting that the protein was MSPl42, 
resulting from processing. In order to further study the subcellular location of the 
recombinant proteins in plant cell, confocal study need to carry out to subcellularly 
locate the proteins. 
For the MSPl 19 constructs, as the protein used for western blotting was not 
denatured, recombinant proteins of various sizes, due to protein association, were 
detected. These immuno-signals all came from the MSPl 19protein as no signal was 
detected from the wild type. Thus, diffused bands were generally observed for the 
MSPl 19 constructs. For the BP-80 construct, two relatively sharper and clearer bands 
were detected at around 19KD and 22KD. The 19KD was the size of the native form 
MSPl 19 while the 22KD protein may be the glycosylated form of the 19KD protein. 
This could be confirmed by performing experiment on deglycosylation. 
Signal peptide plays a critical role in expressing recombinant proteins in plants. 
For example, firstly, for those constructs without the phaseolin signal peptide, no 
protein was detected in the transgenic Arabidopsis (Results 4.2.5) although mRNA 
was detected (Results 4.2.4). Secondly, the GUS fusion constructs without phaseolin 
signal peptide were also not expressed at protein level (Results 4.8), although 
transcript was detected (Results 4.7). Once phaseolin signal peptide was incorporated, 
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either in the protein-targeting or GUS fusion constructs, the transgene could be 
expressed at protein level (Results 4.7). Moreover, the protein expression level of the 
MSPl42 and MSPl 19 constructs containing only the phaseolin signal peptide, at 
around 0.1% of total seed protein, was found to be higher than most of the constructs 
fused with protein-targeting sequences or GUS, generally at around 0.04% of total 
seed protein. It is possible that the MSPl42 and MSPl 19 proteins without a signal 
peptide will end up in the cytosol where they would be degraded. For the lower 
protein expression by the BP-80 construct in comparing with constructs containing 
only phaseolin signal peptide, it may due to the limited amount of BP-80 membrane 
anchoring domain on the membrane of protein storage vacuole to accept the targeting 
protein. 
For the constructs fused with RMR, no protein was detected. The RMR gene 
could be expressed in tobacco culture cell lines in the studies by other group. The 
reason for this difference is unclear at this time. 
Besides, the protein expression levels may be proportionally related to the 
copy numbers which were usually ranged from one to three in tobacco transformation 
and the RNA expression levels. For example, SP/MP42, SP/MP19, SP/MP19-BP80 
and SP/MP19: :EKGUSN-AFVY gave higher protein expression levels when the 
integration copy numbers increased. However, the protein expression levels may also 
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vary amount the plants carrying the same copy number of target genes of the same 
constructs because of the differences in the integration positions of target gene in the 
tobacco plant genome. 
The recombinant proteins were generally found in the cell membrane fraction. 
This may be due to the presence of the a-TIP and BP-80 targeting sequences which 
direct the protein to the membrane of the proteins storage vacuole. 
As a whole, by the use of protein-targeting sequences, the expression of 
MSPl 42 and MSPl 19 can be enhanced up to 0.4% of total seed protein. Also, by fusion 
with GUS or with just the phaseolin signal peptide, MSPI42 and MSPl 19 can also be 
expressed at protein level (up to 0.1%). Thus by using an integrated approach 
combining codon optimization, target protein stabilization by fusion with a stable and 
highly expressed protein, and protein targeting for vacuolar storage, the expression of 
target protein can be significantly enhanced for recombinant production and through 
this strategy, MSPl42 and MSPl 19 can be expressed in transgenic seeds with 
significant amounts, an improvement step in our effort to develop an inexpensive 
malaria vaccine. 
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Chapter 6 Conclusion 
Optimization of cDNA sequence for plant expression is important, but may be 
only limited to transcriptional level. Further optimization, such as incorporating signal 
peptide, protein-targeting signal and fusion protein may be necessary in enhancing 
protein expression and accumulation. 
Through integrating these optimizations, malaria surface antigen MSPl, 
previously could not be expressed at mRNA level, now could be expressed at protein 
level, up to 0.4% as total seed protein. Further work, such as confocal microscopy to 
study the subcellular localization of the recombinant protein in plant cells and to test 
the antigenicity of the plant derived malaria surface antigens (MSPl42 and MSPl 19) 
are important in this line of research and development. 
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